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Abstract 
Autism and Rett Syndrome have been proposed to result from a 
dysfunction in postnatal or experience-dependent synaptic plasticity. Mice 
models in which selected candidate genes were mutated were generated and 
the behavioural phenotype of these mice presents strong similarities with the 
symptoms of human patients.  
Mutations in the X-chromosomal gene that encodes the transcriptional 
repressor methyl-CpG-binding protein 2 (MeCP2) lead to Rett syndrome, thus 
MeCP2-mutant mice have been generated to study the molecular 
mechanisms of the disease. Behavioural abnormalities and the development 
of disease in the MeCP2 deficient mice are similar to human patients. Various 
synaptic impairments have been proposed for these mice, however, it 
remained unclear, which transmitter and receptor systems are predominantly 
involved, and when in development the cellular defects become apparent.  
Neuroligins are a family of cell adhesion proteins involved in synaptic 
maturation and frequently found to be mutated in autistic patients. Deletions of 
all neuroligins leads to lethality, thus individual KO mice in which only one 
isoform was deleted were created in order to investigate the functional role of 
these proteins. We investigate here postnatal changes in synaptic 
transmission of neuroligin-1 deficient mice. 
Neurobeachin (Nbea) is a multidomain neuron-specific protein, highly 
expressed in the brain during development. Although the function of Nbea is 
still unknown, published evidence suggests a role in synaptic membrane 
protein trafficking. The Nbea gene spans in one of the chromosomal fragile 
sites with high risk for autism, and the deletion of this gene in mice leads to a 
lethal phenotype.  
Although all these mice models show no obvious neurodegeneration, the 
mutations always lead to a lethal phenotype, leaving us to investigate if 
dysfunctions in synaptic maturation and transmission may be the cause of 
such a dramatic outcome. We restricted our research to postnatal stages, 
since the ASDs have an interesting development in the first stages of life in 
human patients. For this, we used as a model brainstem respiratory network, 
a neuronal network that is functional at birth. Our aim is to find common 
patterns in postnatal maturation of synaptic transmission in these mice 
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1. Introduction
1.1 From synapses to neural networks
1.1.1 Synapses are the communication unit of the neurons
The term synapse (from Greek, meaning to clasp) was introduced for the first time 
as a physiological concept by Charles Sherrington in 1897. Synapses are higly 
asymmetric contact sites between neurons specialized in chemical transmission. The 
presynaptic site contains a network of scaffolding proteins that ensure the release 
of the neurotransmitter-containing vesicles into the synaptic cleft, as response 
to an action potential that reaches the nerve terminal (Südhof, 2004). From the 
synaptic cleft neurotransmitter binds to specific receptors clustered by postsynaptic 
scaffolding proteins opposite to the active zone. 
There are two categories of chemical transmission between nerve cells, which we 
refer to as fast and slow synaptic transmission. Synaptic transmission at fast synapses 
occurs in less than 1/1000 of a second and is attributable to the ability of the fast-
acting neurotransmitters to open ligand-operated ion channels present in the plasma 
membrane of the postsynaptic cells. In fast excitatory transmission, glutamate opens 
the glutamate receptors AMPA (α-amino-3-hydroxy--methylisoxazole-4-propionic 
acid) and NMDA (N-methyl-D-aspartate), which allows positively charged Na+ and/
or Ca2+ ions to rush into the cell and causes a depolarizing (excitatory) signal to 
be generated in the target cell (Hollmann and Heinemann, 1994). In fast inhibitory 
transmission, GABA or glycine binds to the GABA
A
 or glycine receptors, causing a 
change in the conformation of the receptor, which allows negatively charged chloride 
ions to permeate the cell and causes a hyperpolarizing (inhibitory) signal to be 
generated in the target cell (Farrant and Nusser, 200).
Besides the action-potential-dependent form of neurotransmission there is another 
form of neurotransmitter release, action-potential-independent, called miniature 
synaptic transmission. Although discovered first at the neuromuscular junction (Katz, 
1969) all synapses manifest spontaneous neurotransmitter release in the absence 
of presynaptic action potentials. In most cases, these low-probability release events 
correspond to a single quantum of neurotransmitter that presumably originates from 
fusion of a single synaptic vesicle (Frerking et al., 1997). As for their functional role, 
these spontaneous release events are required for signalling leading to maturation 
and stability of synaptic networks and regulation of local dendritic protein synthesis 
(McKinney et. al., 1999; Sutton et. al., 2004). In contrast to the highly regulated 
and precisely timed nature of action-potential-dependent neurotransmitter release, 
spontaneous synaptic vesicle fusion can only be partially regulated by extracellular 
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calcium, and neuromodulators (Angleson and Betz, 2001; Llano et. al., 2000)
1.2.2 Excitatory/inhibitory balance in neural networks
The human brain contains approximately 101 synapses organized in neural networks. 
The formation of a synapse, synaptogenesis, it is an extremely complex process, 
subject of many regulatory factors. After the initial contact between the axonal 
growth cone and the target neuron, synapses have to assemble at these contacts in 
the right number, with the correct pre- and postsynaptic molecular composition and 
spatial distribution (McAllister, 2007).  The spatial distribution and cell-specificity of 
the synapses determine the complexity and operational roles of neural network. 
For the proper function of a neural network, one of the most important conditions is 
the maintaining of a strict balance between inhibition and excitation. One component 
of the balance is the spatial one, with different networks having different composition 
in the number of excitatory and inhibitory synapses. For example, in the adult 
rodent somatosensory cortex the ratio between excitatory and inhibitory synapses 
is 8.4%/14.6% (De Felipe et. al., 1997), with similar values (7-9%/10-2%) being 
reported for different cortical areas (Beaulieu et. al., 1994; Micheva and Beaulieu, 
1996). In the adult rodent hippocampus the ratio between glutamatergic and GABA 
synapses changes according to the layer analysed: 94.9%/.1% in stratum oriens, 
9.8%/4.2% in stratum radiatum and 84.2%/1.8% in stratum lacunosum moleculare 
(Megias et. al., 2001). Besides the spatial component, the temporal (developmental) 
component of the inhibitory/excitatory balance is as equal as important because 
it permits activity-dependent plasticity while avoiding excitotoxicity or unstable, 
seizure-generating activity. For example, at early developmental stages (due to 
the lack of expression of the K+-Cl- transporter (KCC2)) immature neurons have a 
higher intracellular Cl- concentration, thus both GABA and glutamate are excitatory 
(Ben-Ari et. al., 2004). This early depolarizing GABAergic transmission seems to 
be important for the future excitatory/inhibitory balance since it was shown that 
a premature hyperpolarizing shift of GABA leads to disturbances in this balance 
(Akerman and Cline, 2007). In general, a neural network has to change from a 
functional, but immature phase, with low frequency firing and slow receptors kinetics 
to a mature phase in which is able to respond to various high frequency stimuli 
(Takahashi, 2005; Futai et. al., 2000).
1.2 Autistic spectrum disorders (ASDs)
1.2.1 Features of ASDs
Autistic spectrum disorders (autism, ASDs) are severe neurodevelopmental 
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disorders that affects approximately 1 in 166 born children (DiCicco-Bloom et al, 
2006). The modern basis of autism research were set in 1943 by the Austrian-
American psychiatrist Leo Kanner in a paper that describes the cases of 11 children 
with inborn autistic features of affective contact (Kanner L., 1943). 
According to  DSM-IV-TR and ICD-10 by autistic spectrum disorders is understood 
the spectrum of developmental disorders that comprise impairments in 3 behavioural 
domains: 1) social interaction, 2) language, communication and imaginative play 
and 3) range of interest and activities. Children with autism usually fail to develop 
appropriate interpersonal relationships with their parents or peers, show delay or 
lack in the development of language, present unusual repetitive behaviours and 
abnormal interests and activities. In Asperger syndrome, spoken language and 
non-verbal intelligence are normally developed, however Asperger patients show 
a stereotyped use of language and inability of sustaining a conversation. Mental 
retardation is present in 7 % of the patients (Smalley et al., 1997), but there are 
cases (“autistic savant syndrome”) were intelligence is normal.
Anatomical abnormalities have been identified in many brain areas in autistic patients. 
These include the cerebellum, the brainstem, the cortex, the hippocampus and the 
amygdala (Courchesne et. al., 2002; Moldin et. al., 2007). Head circumference 
and MRI studies showed that neonatal brain undergrowth is followed by rapid and 
excessive brain growth (Courchesne and Pierce, 200). In terms of neuropathology, 
the number of Purkinje cells in cerrebelum and is very low (Ritvo et. al., 1986) 
and the density of packing of neurons in hippocampus and amygdala is increased 
(Belmonte et. al., 2004). It is believed that local connectivity is favoured over 
long-range connectivity, probably due to alterations in synapse elimination and/








(pervasive developmental disorder-not otherwise specified)
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or formation (Belmonte et. al., 2004; Zoghbi et. al., 2004). Based on these data, 
the current hypothesis is that autism might be caused by an imbalance between 
excitation and inhibition in key neural systems (Rubenstein and Merzenich, 2003; 
Polleux and Lauder, 2004).
1.2.2 Rett Syndrome-a special case of autism
Rett Syndrome (OMIM, 31270) is a progressive neurodevelopmental disorder that 
affects mainly girls and the only disorder from the autistic spectrum that is caused 
by mutations in a single gene, the transcriptional repressor methyl-CpG-binding 
protein 2 (MeCP2) (Amir et al., 1999; Chahrour et al., 2007).  It was first described 
in 1966 by the Austrian peditrician Andreas Rett (Rett, 1966), but it took almost 20 
years until the disorder became recognized in the medical community (Hagberg et 
al., 1983). RTT patients are supposed to achieve normal developmental milestones 
until 6-18 months of age when they begin to regress (Hanefeld et al. 1986; Kozinetz 
et al. 1993). As the disease progresses patients present microcephaly, growth 
deceleration, weight lose, muscle hypotonia, lost of purposeful movements of hands 
(Chahrour et al., 2007). Among the autistic features are social withdrawal, loss of 
language, lack of facial expressivity and eye-to eye communication (Nomura, 200). 
Subsequently, patients develop cognitive and motor symptoms, including severe 
ventilation problems (Hanefeld et al. 1986) that may lead to lethal apnea (Kerr and 
Burford 2001). Seizures are usually present at the beginning of the disease but they 
decrease in severity in the teenage years being a minor problem in adulthood (Jian 
et al., 2006).
1.2.3 Genetics of ASDs
One important aspect of ASDs is that the genetic risk is higher than any other 
neuropsychiatric disorder. Kanner himself noted in his pioneering paper (Kanner L., 
1943) that the behaviour of children was abnormal since early infancy, suggesting 
the presence of an inborn, presumably genetic defect. The concordance between 
monozygotic twins is more than 90% and ranges from 10 to 2 % between dyzigotic 
twins (Ritvo et al., 1985; Bailey et al, 1995).  The familial risk of autism ranges from 
2.9 to 4.5 % (Bolton et al., 1994; Jorde et al., 1990), a rate 10 times higher than in 
normal population. Around 15 chromosomal loci have been identified as carrying 
genes involved in autism (OMIM) and whole-genome screens suggest interactions 
of at least 10 genes in the causation of autism (Muhle et al., 2006). Until now there 
is no record of an autistic child having an overtly autistic parent (Folstein, 1977) 
so epigenetic factors must interfere in the initiation of the disorder. Indeed, several 
environmental factors like toxic exposures during pregnancy, teratogens, perinatal 
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insults and prenatal infections have been associated with autism (Muhle et al., 2006). 
Thus, we can conclude that ASDs are behaviourally complex disorders with multiple 
genetic and nongenetic causes that affect early brain development.
In the late years, several linkage studies have managed to enrich the database of 
genes mutated in autistic patients. Several genes, ranging from transcription factors 
like MeCP2, ELN, WNT2 and HOXA1 to genes involved in neuronal migration like 
RELN are mutated in patients of ASDs (Persico and Bourgeron, 2006). However, 
a review of the genes mutated in autism surprises by the amount of genes that 
are involved in synaptic maturation and synaptic function, leading researchers to 
propose that ASDs are disorders of the synapse (Zoghbi, 2004). Special attention 
has been granted to the NLGN-NRX pathway. NLGN-3 and NLGN-4 have been since 
several years connected with autism (Jamain et. al., 2003; Laumonier et. al., 2004), 
but recently mutation in the NRX gene, the transynaptic partner of neuroligins (The 
International Autism Consortium, 2007) and in SHANK-3, a postsynaptic scaffolding 
protein that binds indirectly to neuroligins (Durand et. al., 2007) lead to the hypothesis 
that at least 1% of the autism cases are produce by mutation in the NLGN-NRX 
pathway (DiCicco-Bloom et. al., 2007). Other genes involved in synaptic function 
and autism are the gene encoding Nbea (Castermans et. al., 2003), a protein of 
neuronal membranes or the gene encoding NrCAM, a cell adhesion molecule 
involved in neuronal migration (Persico and Bourgeron, 2006). A large amount 
of mutated genes are encoding for neurotransmitter and postsynaptic receptors. 
Among them are genes that encodes for the serotonin transporter -HTT and one 
subunit of the serotonin receptor, -HT2A, GABR3, a gene that encodes for the β3 
subunit of GABA
A 
 receptor, or genes encoding for glutamate receptor subunits like 
GRIN2A or GRIK2 (Persico et. Bourgeron, 2006; Muhle et. al., 2004). These are all 
genes involved in synaptic transmission, thus suggesting that at least one of the 
underlieng mechanism of autism would be a functionally impaired synapse.
1.3 Genetic mice models of ASDs
In recent years, a new field is emerging in the autism research: behavioural genetics. 
The aim is to bring autism to an experimental level by creating mice models that 
mimic the behavioural traits of the autistic patients. However, given the multifactorial 
origin of autism and its great symptomatic diversity, to create a mouse model that 
captures all of the features of ASDs seems an impossible task. One more reasonable 
approach was to focus on single features of ASDs and then study the underlying 
mechanism of the respective feature. In the case of the genetic mice models, genes 
considered important for ASDs are mutated, deleted or overexpressed in mice in 
order to study the consequences of their dysfunction in the assembly of the whole 
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organism. The importance of these studies is tremendous and they show for the first 
time that the loss-of-function of one gene alone can be enough to produce autistic-
like symptoms in mice without the intervention of environmental factors.  
1.3.1 MeCP2 mice
Several lines of genetically engineered MeCP2 mice have been generated to study 
the cellular and molecular mechanisms of Rett syndrome (Chen et. al., 2001; Guy et. 
al., 2001; Shahbazian et. al., 2002; Collins et. al., 2004; Pelka et. al., 2005). In these 
lines the exons 3 and 4 of the MeCP2 gene were completely deleted on a normal 
(MeCP2-/y; Guy et al. 2001) or an XO background (MeCP2-/O; Pelka et. al., 2006), 
deleted only in the forebrain (MeCP2Cre; Chen et. al., 2001), or truncated (MeCP2308/y; 
Shahbazian et. al., 2002). Similar to patients, the MeCP2-mutant mice are apparently 
normal until some developmental stage, when they begin to exhibit Rett-like 
symptoms: abnormal motor and social behavior, including respiratory irregularities, 
seizures, hypoactivity etc. (see Table 1.1). Since morphological alterations in brain 
architecture are subtle in the MeCP2 lines, most studies have focused on functional 
impairments to explain their profound behavioural abnormalities. In Table 1.1 we 
Table 1.1. Behavioural and neurophysiologichal features of available MeCP2 
mice lines.




(Guy et. al., 
2001)
•	 onset of phenotype at 
3-6 weeks




•	 death at 10 weeks
•	 reduced LTP in cortical 
slices (Asaka et. al., 
2006)
•	 decrease mEPSC 
frequency in 
hippocampal cultures 
(Nelson et. al., 200)
•	 decrease mEPSC 
frequency in autaptic 
cultures accompanied 
by a decrease in 
glutamatergic synapses 
(Chao et. al., 2007)
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review behavioural and neurophysiological findings in these mice lines.  Although 
these studies found opposite effects of MeCP2 on excitatory versus inhibitory 
neurotransmission, it appears likely that an imbalance of synaptic activity is a crucial 
aspect of the phenotype. 
1.3.2 Neuroligin mice
As described above, NLGN3 and NLGN4 genes have been associated with autism 
(Jamain et. al., 2003; Laumonnier et. al., 2004). Tabuchi et. al. (2007) introduced 
the R41C (arg41 to cys) substitution in neuroligin-3 into mice. R41C mutant 
MeCP2 Cre
(Chen et. al., 
2001)
•	 onset of phenotype at a 
later age 
•	 gait ataxia, increased 
anxiety, impaired social 
behaviour
•	 decrease in excitatory 
input and increase in 
inhibitory input in cortex 




•	 onset of phenotype at 6 
weeks




anxiety, learning and 
memory deficits
•	 dies at 1 months
•	 reduced LTP in cortical 
and hippocampal slices 




•	 onset of phenotype at 
10 weeks
•	 initial enhancement 
in motor and learning 
abilities
•	 h y p o a c t i v i t y , 
agressivenes, seizures, 
motor dysfunctions
•	 dies at 1 year




•	 increased number of 
glutamatergic synapses 
(Chao et. al., 2007)
MeCP2-/o
(Pelka et. al., 
2006)
•	 hypoactivity, learning 
deficits and reduced 
anxiety
•	 no data
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mice showed impaired social interactions but enhanced spatial learning abilities. 
At a synaptic level these behavioural changes were accompanied by an increase 
in inhibitory synaptic transmission with no apparent effect on excitatory synapses. 
The R41C substitution represents a gain-of-function mutation since the deletion 
of neuroligin-3 did not cause such changes. Tabuchi et. al. (2007) concluded 
that increased inhibitory synaptic transmission might contribute to human autism 
spectrum disorders. A mutant mouse lacking the murine ortholog of human NL-4 
presents even more autistic-like features (Jamain, 2008). The NL -4 KO mice show 
impaired social interaction with other mice and reduced vocalization in the presence 
of female mice. Moreover, NL-4 mice show reduction in the total brain size and 
that is the key anatomical finding in autistic patients. The specific regions that are 
reduced in size, cerrebelum and brainstem, are regions previously shown to have a 
reduced size in autistic patients.
1.4 MeCP2 and Rett syndrome
1.4.1 MeCP2 is a transcriptional repressor
MeCP2 was identified as a mammalian protein that binds methylated CpG 
dinucleotides (Lewis et. al., 1992) leading to repressed transcription in vitro (Nan 
et. al., 1997). The protein is composed of three domains: the MDB (methyl-binding 
domain), the TRD (transcriptional repressor domain) and a C-terminal domain 
(Chahrour and Zoghbi, 2007). MDB binds to the methylated CpGs of target genes 
and TRD recruits the corepressor Sin3A and histone deacetylases (HDAC 1 and 
2) leading to compaction of chromatin and inhibition of transcription (Jones et. al., 
1998; Nan et. al., 1998). The transcriptional repressor activity of MeCP2 can be also 
through direct interaction between its C-terminal domain and chromatin (Nikitina et. 
al., 2007). As for the importance of different domains in the context of Rett Syndrome, 
it has been shown that mutation in all domains cause the disorder, although the 
severity of the disorder may vary (for example, mutations in the C-terminal domain 
have been associated with milder symptoms of RTT patients. (Christodoulou et. al., 
2003; Chahrour et. al., 2007).
1.4.2 MeCP2 is involved in synaptic development
Based on the temporal expression patterns of MeCP2 it has been hypothesised 
that the main function of the protein is to modulate the activity of genes involved in 
synaptic development (Shahbazian et. al., 2002, Johnston et. al., 2001). MeCP2 
levels are low during embryogenesis and they are progressively increasing with the 
postnatal neuronal maturation (Balmer et. al., 2003; Kishi et. al., 2004; Matarazzo et. 
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al., 2003; Mullaney et al., 2004; Shahbazian et. al., 2002). For example, in olfactory 
receptor neurons (ORNs) high expression levels of MeCP2 are connected with 
maturation and they precede the onset of synaptogenesis (Matarazzo et. al., 2003). 
In cortex expression of MeCP2 is increased within each layer during the formation of 
the respective layer and synaptogenesis (Mullaney et. al., 2004). Recent data from 
KO mice support the synaptic functions of MeCP2. In general, although changes 
in brain morphology are subtle in KO mice they present several impairments in 
synaptic transmission and plasticity (see Table 1.1). Moreover, deletion of MeCP2 
in mice leads to delay in neuronal maturation and synaptogenesis (Fukuda et. al., 
2004). A role in synaptogenesis for MeCP2 it is implied also by its target genes, 
since its transcriptional repression is localized at specific promoters crucial to 
brain development and plasticity, including those regulating levels of brain-derived 
neurotrophic factor (BDNF), the transcription factor distal-less homeobox 5 (DLX5), 
ubiquitin-protein ligase E3A (UBE3A) and the GABA receptor subunit GABRB3 
(Chahrour et. al, 2007).
1.5 Neuroligin-1 and ASD
1.5.1 Function of Neuroligin-1
Neuroligins (NLs) are cell adhesions postsynaptic proteins that interact with the 
presynaptic α- and β-neurexins (Ichtchenko et al., 1995; Song et. al., 1999; Boucard 
et. al., 2005). The neuroligin family comprises 4 genes in rodents (NLGN1-4) and 
5 members in humans and higher primates (NLGN1-3, NLGN4X and NLGN4Y) 
(Ichtchenko et al., 1995; Jamain et. al., 2003). It has been proposed that NLs, along 
with their transsynaptic partners, neurexins, act as transneuronal signals and recrute 
the synaptic component necessary for the synaptic formation (Craig and Kang, 
2007). NL-1 expressed in HEK293 cells cocultured with neurons induces presynaptic 
differentiaon at the site of contact (Scheiffele et. al., 2000; Boucard et. al., 2005; 
Chih et. al., 2006). It was shown that different members of the family localize at 
different type of synapses. While NL-2 localize at inhibitory synapses (Varoqueaux 
et. al., 2004), NL-1 has been associated with excitatory synapses (Song et. al., 
1999). Overexpression of NL-1 in neurons leads to increased density of excitatory 
synapses and clustering of postsynaptic excitatory components accompanied by 
increase in the frequency and amplitude of miniature excitatory currents (Dean et. 
al., 2003; Chih et. al., 2005). These data suggest a role for NLs in synaptic formation, 
however deletion of all major NLs in mice didn’t lead to changes in synaptic density 
(Varoqueaux et. al., 2006). On the other hand, NL TKOs show a severe reduction 
in both excitatory and inhibitory spontaneous currentssuggesting that NLs play an 
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essential role in maintaining the proper function of synapses (Varoqueaux et. al., 
2006). Recent research (Chubykin et. al., 2007) shows that deletion of NL-1 in mice 
results in changed AMPA/NMDA ratio and proposes a role for NL1 in the activity-
dependent maturation of NMDA synapses. 
1.5.2 NLs and autism
The connection between neuroligins and autism started in 2003 with the finding that 
mutations of NL-3 and NL-4 were found in two brothers with ASD (Jamain et. al., 2003). 
Other mutations in the NL-3 and NL-4 genes were subsequently found (Laumonnier 
et. al., 2004; Yan et. al., 2004). Recent studies (The Autism Consortium Project, 
2007) show the binding partners of neuroligins, neurexins to be candidate genes 
for autism. A mutation in Shank-3, a scaffolding protein that binds indirectly with NL, 
was also found in autistic spectrum disorders (Durand et. al., 2007). Thus, mutations 
in the NL-NRX pathway seem to be one cause of ASDs. Indeed, reproduction of 
the NL-3 mutations (Tabuchi et. al., 2007) or deletion of NL-4 (Jamain et. al., 2008) 
leads to autistic-like behaviours in mice. NL-1, the protein that is the object of our 
present study has not been mutated in ASDs. However, since neuroligins seem to 
exercite similar functions at different synapses (Dean et. al., 2003; Chih et. al., 2005; 
Chubykin et. al., 2007) analysis of the NL-1 KO may bring informations about the 
exact mechanism through which mutations in this family of proteins lead to ASDs.
1.6 Neurobeachin and ASD
1.6.1 Structure and function of Nbea
Neurobeachin was initially discovered as a component of neuronal synapses. The 
protein is 3000 a.a. long and is peripherally associated with polymorphic tubulo-
cisternal endomembranes and a minority of postsynaptic plasma membranes 
(Wang et al., 2000). In particular, neurobeachin concentrates at trans-Golgi-near 
membranes, and its membrane association is stimulated by GTP and antagonized 
by brefeldin A (Wang et al., 2000). These circumstances suggest a functional link 
with a GTP-dependent vesicle coat and an involvement in the post-Golgi sorting or 
targeting of neuronal membrane proteins, including proteins of postsynaptic plasma 
membranes. Whereas neurobeachin expression seems to be restricted to neurons 
and endocrine cells, an isoform expressed in many tissues, Lrba, was discovered 
as a gene product whose expression is upregulated in B cells and macrophages in 
response to bacterial lipopolysaccharides (Wang et al., 2001).  Neurobeachin but 
not Lrba can bind the regulatory subunit RII of protein kinase A, qualifying it as an 
AKAP (A-kinase anchor protein) (Wang et al., 2000).
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1.6.2 Nbea null-mouse
The importance of neurobeachin for the functioning of the nervous system is 
underscored by the severe phenotype of mouse mutants. A Nbea null mutant 
mouse was obtained by coincidental insertion mutagenesis (Su et al., 2004). 
Homozygous Nbea (-/-) mice were found to die immediately after birth from 
breathing paralysis, due to a complete block of evoked synaptic transmission at 
the neuromuscular synapse (NMS) whereas nerve conduction, NMS morphology 
and spontaneous synaptic vesicle release were normal. Electrophysiological 
analysis of neuromuscular transmission in these mice indicated that the defect was 
presynaptic, most likely affecting either action potential invasion of nerve terminals 
or the coupling of action potential invasion to calcium-dependent neurotransmitter 
exocytosis. Brain cytoarchitecture of the Nbea mutant mice was apparently normal, 
but a functional analysis of neuro-neuronal synapses was not carried out (Su et al., 
2004). Neurobeachin appears to be expressed pan-neuronally (Wang et al., 2000), 
suggesting that it is functionally important not only in motoneurons but throughout 
the nervous system. 
1.6.3 Nbea and ASD
The human neurobeachin gene (NBEA) is large (80 kbp, 7 exons) and contains a 
region of enhanced chromosomal fragility (Savelyeva et al., 2006). A heterozygous 
rearrangement of NBEA was characterized in a patient with autism (Castermans 
et al., 2003), and in three other autism cases chromosomal deletions in the NBEA 
region were identified (Smith et al., 2002; Barrett et al., 1999; Ritvo et al., 1988). The 
above findings implicate neurobeachin as one genetic factor that can contribute to 
the etiology of ASD.
1.7 Early development of ASDs
Perhaps the most surprising observation in the field of autism research is that for 
this disorder of neural development, there are very few studies of early neural 
development. The genetic and developmental processes that organize developing 
brain networks and presumably are dysfunctional in the autistic brains are largely 
unstudied in the early developmental time period in both human patients and mice 
models of the disorder. For instance, in the case of Rett Syndrome, both RTT          
patients and MeCP2-mutant mice are born normally and show a period of apparently 
undisturbed postnatal development before clinical symptoms become obvious. 
However, it is probable that mild symptoms appear earlier since the expression 
of MeCP2 in normal brains starts already during the embryonic development, 
and reaches a peak in many brain regions before the onset of related symptoms 
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(Shahbazian et al., 2002; Mullaney et al., 2004). Clinical research has begun to 
emphasize the problems of young RTT and autistic patients (Einspieler et al. 2005; 
Nomura 2005; Trevarthen and Daniel 2005). The analysis of home made videos of 
girls later diagnosticized with Rett showed that abnormal hand movements and sleep 
disturbances are detectable from the first 4 months of life (Einspieler et. al., 2005; 
Nomura, 200). Impairments in social behaviour appear on video at 11 months in an 
autistic patient (Trevarthen and Daniel 200). Consistently, studies on young MeCP2-
deficient mice revealed that more subtle behavioural alterations might be present 
early in development. Picker et. al. (2006) shows that starting with postnatal day  
MeCP2 null mice exhibit dramatic increases  in ultrasonic vocalizations in response 
to social isolation. Other abnormalities of younger mice are hypoactivity, delay in 
the acquisition of postural reflexes and impaired growth maturation, abnormalities 
that resemble symptoms of RTT girls (Santos et al. 2007). Moreover, glutamatergic 
synapses in MeCP2 KO mice are altered in autaptic cultures and in vivo in the first 
2 weeks of development (Chao et. al., 2007) indicating that cellular symptoms may 
be present in these mice much earlier than it was believed. Thus, a more thoroughly 
investigation of early developmental events in both human patients and mice models 
could bring more insight about the mechanistic of this terrible disorder. 
1.8 Aim of the project
We started this project shortly after the first article that proposed that autistic spectrum 
disorders are disorders of the synapse (Zoghbi, 2003). Since then there has been 
a lot of work published in the field of autism research, but still most of the questions 
remain open. In this project we investigated the effect on synaptic function induced 
by the deletion in mice of three proteins (MeCP2, NL-1 and Nbea) associated with 
ASDs and with synaptic development. Our approach was novel because we choose 
to investigate the mice models early in development, in the first postnatal week. Two 
main questions guided us during this project: 
When does the synaptic imbalance appears in our mice models and which transmitter 
systems are affected?
What structural impairments of synaptic components are the underlying causes of 
the functional imbalance? 
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2. Materials and methods
2.1 Experimental model
To investigate the early synaptic dysfunctions in our mice models we studied 
neurotransmission in the respiratory brainstem network. Normal synaptic transmission 
and development has extensively been characterized in this brainstem model (Ritter 
and Zhang 2000) and various defects of synaptic function have been successfully 
studied in this system (Missler et al. 2003; Varoqueaux et al. 2006; Zhang et al. 
2005).
We had particular reasons for choosing the respiratory brainstem network as a 
working model in the case of each mutant mouse analysed in the present work. 
The resting ventilation activity is strongly impaired in adult MeCP2-deficient mice 
(Stettner et al. 2007; Viemari et al. 2005) at least partly due to impaired synaptic 
function (Stettner et al. 2007). Thus, in the case of MeCP2 KO mice, we chose this 
model in order to look for early signs of impairments in ventilation and its underlying 




















































































































































Figure 2.1 Respiratory brainstem network in mice. (A) Schematic sagital view of the mice brain 
(Franklin and Paxinos, 1997). (B) Slice from the respiratory medulla (in red in (A)) with the main 
nuclei. NA, nucleus ambiguous; RVLM, rostroventrolateral medulla; XII, hypoglossus nucleus. (B) 
Infrared contrast enhaced image from a patched neuron in RVLM
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mice died at birth due to respiratory failure (Varoqueaux et. al., 2006) and we 
wanted to compare the role of NL-1 in comparison with other neuroligins. As for 
Nbea KO mice, since they die at birth, the respiratory brainstem network was the 
most appropiate to investigate the causes of the lethal phenotype.
We recorded neurons in the rostroventrolateral medulla (RVLM), an area of the 
reticular brainstem formation, that contains pre-Bötzinger complex (PBC), (Fig. 
2.1) a neuronal network responsible for generating the respiratory rhythm (PBC, 
c.f. Richter and Spyer 2001). No further characterization of these neurons was 
performed in order to test whether these are inspiratory or other respiratory neurons, 
but, as Smith et. al. (1991) describes it, majority of neurons from RVLM are involved 
in ventilation.
To ensure that the observed phenotypes are not particular to RVLM neurons we 
extended our experiments to neurons from the hypoglossal nucleus (NH) (Fig. 2.1), 
a nucleus that synchronises with the firing of neurons in PBC (Tokumasu et. al, 
2001) and controls movements of the tongue (Lowe et al, 1980). Neurons from NH 
receive mixed inhibitory and excitatory inputs from the ipsilateral PBC neurons (Li 
et. al, 2003). 






Differential pressure transducer (CD15 
Carrier Demodulator)
ValiDyne Engineering, USA
Vibratome slicer (752M Vibroslice) Campden IInstruments, UK
Water pump (505LA) Watson Marlow, USA
Water bath (D8) Haake, Germany
Pipette puller (P87) Sutter Instrument Co., USA
Light microscope (Axioscope 2 FSplus) Zeiss, Germany
Patch-clamp amplifier (WPC-100) E.S.F. electronic, Germany
Micromanipulator (1 MM3A) Kleindiek nanotechnik, Germany
Isolated pulse stimulator (M2100) A-M systems Inc., USA
Pressure ejector (PDES-2L) NPI electronic, Germany
A/D converter (Digidata 1322) Molecular Devices, USA
Confocal microscope (LSM 510 Meta) Zeiss, Germany
Cryoscopic osmometer (Osmomat 030) Gonotec, Germany
Electrophoresis power supply (EPS601) Amersham Biosciences, Germany





Borosilicate glass micropipettes (GF150-
10F)
Clark Electromedical Instruments, UK
Membrane hybond ECL Amersham Biosciences, Germany
Whatman GB58 Blotting paper B002 Heinemann Labortechnik GmbH, 
Germany
Hamilton syringe Hamilton, USA
Microscope slides Menzel-Gläser, Germany
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Software
Use Name and manufacturer
Patch-clamp recording and analysis pClamp 9.2, Molecular Devices, USA
MiniAnalysis, SynaptoSoft, USA
Western analysis Bio-1D, Vilber Lourmat, France
Microscopy analysis Zeiss analysis software, Zeiss, 
Germany
Statistics Instat 3, GraphPad Software Inc., 
USA
Prism 4.0, GraphPad Software Inc., 
USA
Figures and tables Prism 4.0, GraphPad Software Inc., 
USA
Adobe Illustrator CS, Adobe, USA
Microsoft Excel, Microsoft Corp., USA
Image processing Adobe Photoshop CS, Adobe, USA
Text processing Microsoft Word, Microsoft Corp., USA
Adobe InDesign CS, Adobe, USA
2.2.2 Drugs and solutions
2.2.2.1 Chemicals
Name Manufacturer
Acetic acid Merck, Germany




Aprotinin A 1153 Sigma-Aldrich, Germany
Bicuculline Sigma-Aldrich, Germany
BSA Amersham Pharmacia Biotech, UK
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TTX Alomone Labs, Israel




118 mM NaCl, 3 mM KCl, 1.5 mM CaCl2, 1 mM MgCl
2
, 25 mM NaHCO
3





, 5 mM glucose
INK intracellular solution:
140 mM KCl, 1 mM CaCl
2
, 10 mM EGTA, 2 mM MgCl
2
, 4 mM Na
3
ATP, 0.5 mM 
Na
3




, 30 mM TEA-Cl, 1 mM CaCl
2
, 10 mM EGTA, 2 mM MgCl
2
, 4 mM 
Na3ATP, 0.5 mM Na
3
GTP, 10 mM HEPES
For biochemical procedures
Homogenization buffer:
320 mM sucrose, 5 mM Hepes-NaOH (pH 7.4), 0.1 mM EDTA, proteases inhibitors 
(aprotinin, leupeptin)
Stacking gel buffer (Upper Tris):
0.5 M Tris (pH 6.8); 0.4% SDS
Separation gel buffer (Lower Tris):
1.5 M Tris (pH 8.8); 0.4% SDS
10x SDS-PAGE-running buffer (for 1 L):
30.2 g Tris-HCl; 144g Glycine; 10 g SDS 
10x Transfer buffer (for 1 L):
31.2 g Tris-HCl; 144 g Glycine; 5 g SDS
1x Transfer buffer (for 100 ml)
10 ml 10x transfer buffer; 20 ml methanol; 70 ml H
2
0
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Ponceau-S solution (for 1 l):
2 g Ponceau-S; 50 ml Acetic acid, 950 ml H
2
0
10 x TBS buffer:
1.37 M NaCl, 200 mM Tris-HCl (pH 7.6)
 
1x TBS –Tween 20 buffer (for 1 L)
100 ml TBS, 900 ml H
2
0, 1 ml Tween 20
Blocking buffer:
5 % non-fat powder milk in TBS-Tween 20
For immunocytochemistry
PFA 4% (for 1 L):
80g PFA in 0.1 mM PB
PB (phosphate buffer for 2 L):


















PBS (for 1 L):
10 mM PB, 150 mM NaCl, 2,7mM KCl, 





Antibodies Raised in Provenience
Anti-Actin rabbit S i g m a - A l d r i c h , 
Germany
Anti-Complexin 2 rabbit Prof. Dr. M. Missler
Anti-Dynamin rabbit Prof. Dr. M. Missler




1 goat Santa Cruz, USA
Anti-GABAR
A
2 rabbit Abcam, UK
Anti-GABAR
A
3 rabbit Abcam, UK
Anti-GABAR
A
4 rabbit Abcam, UK
Anti-GABAR
ß
3 goat Santa Cruz, USA
Anti-Gephyrin mouse Synaptic Systems, 
Germany
Anti-GluR 1 rabbit Chemicon, USA
Anti-GluR 2/3 rabbit Chemicon, USA
Anti-Gephyrin mouse Synaptic Systems, 
Germany
Anti-GlyR mouse Alexis, UK
Anti-HSP70 goat Santa Cruz, USA
Anti-Mint1 rabbit Prof. Dr. M. Missler
Anti-Munc18 mouse Prof. Dr. M. Missler
Anti-NMDAR1(54.1) mouse Upstate, USA
Anti-NMDAR1(54.2) mouse Synaptic Systems, 
Germany
Anti-NMDAR2A rabbit Chemicon, USA
Anti-NMDAR2B rabbit Chemicon, USA
Anti-PSD-95 mouse Abcam, UK
Anti-Rab3A mouse Prof. Dr. M. Missler
Anti-SNAP-25 mouse Synaptic Systems, 
Germany
Anti-Syntaxin1 mouse Prof. Dr. M. Missler
Anti-Synaptotagmin 1 rabbit Prof. Dr. M. Missler
Anti-Synaptophysin mouse Dako, Denmark
Anti-Synaptobrevin mouse Prof. Dr. M. Missler
Anti-Synapsin1&2 rabbit Prof. Dr. M. Missler
Anti-VIAAT rabbit Chemicon, USA
Anti-VGLUT 1 rabbit Chemicon, USA
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Anti-mouse IgG Goat HRP Chemicon, USA
Anti-goat IgG (H+L) Donkey HRP Dianova, USA
Anti-rabbit IgG Donkey HRP Amersham 
Biosciences, UK
Rabbit Cy5 IgG (H+L) Goat Cy5 Dianova, USA




All animal experiments were carried out in accordance with the guidelines of the 
Ethics committee of the University of Göttingen.
2.3.1.1 MeCP2 -/y mice
We used the strain [B6.129P2(C)-Mecp2 tm1–1Bird] as a mouse model for Rett 
syndrome (17). The mice were obtained commercially from The Jackson Laboratory 
(Bar Harbor, ME) and maintained on a C57BL/6J background. Hemizygous mutant 
Mecp2 males were generated by crossing heterozygous knockout females with 
C57BL/6J wild-type males. All experiments were performed on hemizygous (-
/y) MeCP2 males and their sex- and age-matched littermate controls (+/y). We 
used (-/y) MeCP2 males because heterozygous (+/-) MeCP2 female mice have 
a heterogeneous phenotype as a result of the X-inactivation profile of the X-
linked MeCP2 gene. Genotyping was performed as described before (Stettner et 
al. 2007), essentially following The Jackson Laboratory protocols (forward primer 
CreF, 5’–GACCGTACACCAAAATTTGCCTG–3’; reverse primer CreR, 5’́–
TTACGTATATCCTGGCAGCGATC–3’). Many thanks to Anna-Maria Bischoff from 
the University of Göttingen for taking care of the breeding, handling, and genotyping 
of the mice.
2.3.1.2 NL1 KO mice
NL-1 KO mice were generated as previously described (Varoqueaux et. al., 2006). 
To generate mice that lacking NL-1, the exon sequence covering the translational 
start site and at least 380 bp of 5´ coding sequence of the gene were deleted by 
homologous recombination in embryonic stem cells.The mice were generated and 
generously supplied by the lab of Prof. N. Brose. Many thanks to Ute Bormann for 
breeding and handling the mice and to Frederique Varoqueaux for taking care of all 
the organizational problems.
2.3.1.3 Nbea KO mice
Nbea KO mice were generated from the gene-trap ES cell line RRK418 obtained 
from BayGenomics, a member of the International Gene Trap Consortium. This 
Sv129-derived cell line has integrated the gene-trap vector pGT21xf in intron 6 of the  
Nbea gene. Genomic DNA from RRK418 around the integration site was amplified 
by PCR and sequenced. The vector was found to have inserted 385 bp downstream 
of exon 6. The first 389 bp of the gene-trap vector had been lost in the course of 
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insertion, but the sequence loss was upstream of the vector’s splice acceptor site 
and did not affect the function of the vector (Fig. 1). ES cells were injected into 
C57Bl/6N blastocysts and implanted into foster mothers at the Uppsala University 
Transgenic Facility (UUTF). Chimeric male offspring were mated with C57Bl/6N 
females and agouti pups were genotyped by PCR of genomic DNA. The line was 
maintained by backcrossing of heterozygous transgenic animals with C57Bl/6N 
mates. For PCR genotyping, three primers were employed in a single amplification 
reaction: a single forward primer for both the wt and the transgenic allele in exon 6 
(Ex6F, 5’-TTTCGTACTAGCAAAGGAGTG-3’) and specific reverse primers for the 
wt and transgenic alleles in intron 6 (Int6/7R, 5’-GACTAAAAGATGGCAGCTCTC-
3’) and in the gene-trap insert (Trap5’R, 5’-TTTGAGCACCAGAGGACATC-3’), 
respectively (see Fig. 1A). Because of the length of the gene-trap insert (8.3 kb), 
the wt reverse primer produces an amplification product only from the unmodified 
allele. The mice were generated by Prof. Dr. Manfred W. Killiman from University 
of Uppsala and breed by Prof. Dr. Markus Missler from the University of Göttingen 
(currently Head of the Anatomy Institute at the University of Münster). Many thanks 
to Sandra Gerke from University of Göttingen and Kai Kerkhoff from University of 
Münster for breeding, handling, and genotyping of the mice.      
2.3.2 Ventilation recordings
Ventilation patterns were recorded by whole-body pletysmography, for which 
unanaesthetized P1 (for NL1 mice) or P7 (for MeCP2 mice) wild-type and their KO 
littermates were placed in a 50 ml closed chamber connected to a differential pressure 
transducer (CD15 Carrier Demodulator, ValiDyne Engineering, Northridge, CA). 
The analog signal of ventilation-related changes of air pressure was amplified and 
digitized using an A/D-converter (DigiData 1322A, Molecular Devices, Sunnyvale, 
CA), and analyzed using commercially available pClamp 9.2 software (Molecular 
Devices, Sunnyvale, CA).
2.3.3 Electrophysiology
2.3.3.1 Brain slice preparation
The preparation of transverse brainstem slices containing the rostroventrolateral 
medula (RVLM) and hypoglossal nucleus (NH) followed the general procedure of 
making thin slices from the tissue of mouse central nervous system described in 
Zhang et al. (1999). Mice were decapitated at C3-C4 spinal level. The whole brain 
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was carefully removed from the cut-open skull, immediately transferred into ice-cold 
artificial cerebrospinal fluid (ACSF), which was already bubbled with carbogen (95% 
O
2
 and 5% CO
2
). The brainstem was separated from the cerebellum and forebrain. 
Transverse 200 µm-thick slices were cut using a vibratome slicer (752M Vibroslice, 
Campden IInstruments, UK). Sectioning of the brainstem was done from the rostral 
to caudal part and fourth ventricle was used as a marker for the start of the region 
of the interest. After sectioning, each slice was quickly placed into an incubation 
chamber containing aerated ACSF. Slices were kept at 28-30 ºC
2.3.3.2 Whole-cell patch-clamp
All electrophysiological recordings were done on acute brainstem slices containing 
RVLM and NH. The slices were placed into the glass bottomed recording chamber 
and fixed by platinum wire with a grid of parallel nylon threads, to avoid of slice 
dislocation. The slice was continuously perfused with aerated extracellular solution 
during experiments, using a pump (Watson Marlow, USA).The brain slices were 
visualised under an Axioscope  2 FSplus microscope (Zeiss, Germany) using a 5x 
and a 40x water immersion objective, respectively. Patch pipettes were pulled from 
borosilicate glass micropipettes (GC 150-10F, Clark Electromedical Instruments, 
UK) using a multistage puller (P87, Sutter Instrument Co. Novato, USA). Resistance 
of the electrodes varied between 4 and 8 MΩ. Recordings were performed using a 
WPC-100 amplifier (ESF, Göttingen). All experiments were performed in the voltage-
clamp configuration, using “whole-cell patch-clamp” technique. The first step in this 
method is formation of a gigaseal, by touching the cell surface with pipette and 
applying gentle suction. After application of a short pulse of negative pressure to the 
electrode the patch of membrane under the pipette is ruptured, reaching the whole-
cell configuration. After establishing of whole-cell configuration the recordings were 
performed at a holding potential of -70 mV.
The membrane currents were filtered by a four-pole Bessel filter set at a corner 
frequency of 1 kHz and digitized at a sampling rate of 5 kHz using the DigiData 1322 
interface (Molecular Devices, USA). All experiments were conducted at 32 ºC.
2.3.3.3 Spontaneous and miniature PSCs recordings
For spontaneous and miniature experiments, patch electrodes were filled with INK 
solution (see 2.1.2.2). As the concentration of chloride-ions was similar between 
intra- and extracellular solutions, the reversal potential of chloride was close to 0 mV. 
Spontaneous GABA- and glycinergic IPSCs were recorded at a Cl- reversal potential 
of about 0 mV in 10 µM CNQX and 40 µM AP5. Miniature GABA- and glycinergic 
PSCs (mIPSCs) were recorded with the same drugs, but in presence of 0.5 µM 
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tetrodotoxin (TTX) to block action potentials. Spontaneous glutamatergic EPSCs 
were recorded in the presence of 1 µM strychnine and 1 µM bicuculine. Miniature 
glutamatergic EPSCs  (mEPSCs) were recorded in presence of the same drugs, 
again with extra 0.5 µM tetrodotoxin (TTX). In control and after drug applications, 
spontaneous and minis were recorded in presence for 3 minutes, Signals with 
amplitudes of at least 2 times above the background noise were selected.
2.3.3.4 Evoked PSCs recordings
For experiments of evoked EPSCs, patch electrodes were filled with INK solution 
(see 2.1.2.2). Evoked glutamatergic and GABAergic/glycinergic PSCs were      
recorded from hypoglossal neurons in the presence of 1 µM strychnine and 1 µM 
bicuculline or 10 µM CNQX and 40 µM AP5, respectively. PSCs were evoked by 
stimulations of axons of interneurons close to the RVLM using a bipolar platinum 
electrode. A pulse stimulator (A-M systems Inc., USA) was used to apply currents of 
different stimulation strengths. Peak amplitudes were averaged from 25 consecutive 
responses. To monitor changes in input resistance, current responses to a -10 mV 
voltage step (20 msec) from a holding potential of -70 mV were recorded before 
every fifth stimulus. In all experiments the distance between the stimulation and 
recording electrodes was similar between slices of different genotypes.
2.3.3.5 Drug application experiments
For drug application (“puff”) experiments patch electrodes were filled with INK 
solution (see 2.1.2.2). Drug was directly applied in close proximity to neurons by 
glass pipettes filled with muscimol, glycine, NMDA or AMPA (all 5 mM) dissolved in 
above bath solution. For minimizing the variation between experiments, we kept tip 
size of pipette, pressure (0.5 mbar) and time (500 ms) constant for all experiments. 
In addition, the distance between pipette tips and the cell were monitored using 
a LCD camera, and was also kept constant between different experiments. The 
remaining variation between experiments was random in nature, and was not 
specifically related to the genotype of the tested animals, especially because the 
experimenter was unaware of the genotype.
2.3.3.6 Sucrose experiments
In order to elicit a hypertonic response (Rosenmund and Stevens 1996), sucrose 
(300 mM) was applied in the perfusion flow for 2 seconds. The patch electrodes 
were filled with INK solution (see 2.1.2.2). 
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2.3.3.7 Voltage-gated channels recordings
Voltage-activated currents were measured from neurons of the RVLM with patch 
electrodes containing INLOW intracellular solution. After establishing the whole-
cell configuration, membrane capacitance serial and membrane resistances were 
estimated from current transient induced by 20 mV hyperpolarization voltage 
commands from a holding potential of -70 mV. The serial resistance was compensated 
by 80%. For correction of current measurements P/4 protocol was used. According           
to this protocol four leak-subtraction pulses were applied immediately before the 
main command step and leak currents were subtracted.
2.3.3.8 Kinetic analysis



















 were their respective decay time constants (Jonas et al. 1998; Nabekura 
et al. 2004).To allow for easier comparison of decay times between experimental          
conditions, the two decay time components were combined into a weighted mean 



















In some experiments (see Fig. 3.3) mIPSCs were considered to have a mono-
exponential decay when the relative contribution of one of the exponential 
distributions was <1%. Thus, the decision about whether a single mIPSC decayed 
with a single or dual component was completely objective. mGPSC decay was fitted 
to a monoexponential function.
2.3.3.9 Data analysis
All data are expressed as mean ± standard error of the mean. P-values represent the 
results of two-tailed unpaired Student’s t tests, with or without Welch’s correction, 
depending on the distribution of the data (tested with a Kolmogorov-Smirnov test). 
Data acquisition and analysis was done using commercially available software: 
pClamp 9.0 (Molecular Devices, Sunnyvale, CA), MiniAnalysis (SynaptoSoft, 
Decatur, GA) and Prism 4 (GraphPad Software, San Diego, CA).
2.3.4 Biochemical procedures
2.3.4.1 Protein extracts preparation
Brains from littermate wild-type and KO mice were quickly removed from the cut-
open skull, btrainstem was cut and immediately frozen by immersion in liquid 
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nitrogen and stored at -80ºC. The tissues of selected genotypes were homogenized 
in omogenization buffer with a glass Teflon homogenisator (homgenplus, Schütt) at 
setting 1200 rpm. Afterwards the homogenate was aliquoted ant stored at -20ºC. The 
protein concentration was measured with the Lowry assay (see in section 2.3.1). For 
using the protein sample was resuspended in 3x loading buffer and boiled at 100ºC 
for 5 min. The boiling denatures the proteins, unfolding them completely.
2.3.4.2 Protein concentration estimation
The total protein concentration was determined according to Lowry assay, using 
the total protein kit from Sigma with bovine albumin serum (Sigma-Aldrich, St.Louis 
MO) as a standard. At first a BSA standard curve with sample of known protein 
concentration was prepared. A series of dilutions (0, 25, 50, 100, 200, 300, 400µg/
ml) were made in replicates of three with a final volume of 50 µl. 
Protein samples (1-3 µl) were diluted in SDS to 50 µl. Each protein concentration 
measurement was performed in triplicate. The following step was the transferring 
of standards and samples into microplate (96 well plate; Sarsdedt Newton Inc., 
Newton USA). The Lowry reagent (50 µl) was added to each well and incubated for 
20 min at RT, which was followed by addition of 25 µl of Folin-Ciocaltau’s phenol 
reagent. The addition this reagent leads finally to an intensive blue staining, which 
was measured by absorbance at e wavelength between 500 and 800 nm. All 
absorbance estimations were done using a Microplate reader (BioRad). Samples 
without protein were served as reference. Analyses and statistics of the standard 
curve were performed using Sigma plot software.
2.3.4.3 SDS-PAGE
SDS-PAGE is a common biochemical method for protein separation. According to 
this method, proteins can be separated based on their molecular weight, as they 
move through polyacrilamide gel in response to an electric field. Protein samples 
before being subjected to electrophoresis are mixed with buffer containing SDS and 
ß-mercaptoethanol. SDS mediates the disruption of three-dimensional structure of 
proteins by breaking non-covalent bonds and the loading of proteins with negative 
charges. ß-mercaptoethanol breaks disulfide bonds.  Protein gel electrophoresis 
was performed using a minigel vertical apparatus. Glass-plate sandwich was built 
for preparation of the gel. The glass walls (10.5 x 10) were cleaned, sealed with 
silicone rubber band and clamped.  After assembling the glass-plate sandwich 
of the electrophoresis apparatus, the stacking and separating gel solutions were 
prepared.
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Solution Separation gel (10%) Stacking gel (5%)
AA30 2.5 ml 0.325 ml
Tris buffer pH 8.8 1.875 ml
Tris buffer pH 6.8 0.787 ml
dH
2
0 3.125 ml 1.525 ml
Themed 7.5  µl 3.7 µl
APS 40 µl 20 µl
The separation gel was poured first and the surface was covered with isopropanol, 
which straightens the surface of the gel. After the gel polymerized (in 
30-40 min), isopropanol was removed. The stacking gel was then pored over 
the separation gel, and the comb of 0.6 mm thickness was inserted. When the 
stacking gel was polymerized (in 15-20 min), the comb and silicone rubber band 
were removed, and the gel was then placed into the gel electrophoresis apparatus 
and filled with running buffer. Shortly before loading the samples were boiled. The 
molecular weight marker (for estimating the molecular weight of unknown proteins) 
and samples were loaded into the wells of stacking gel using a Hamilton Syringe 
(Hamilton Company; Reno, Nevada, USA). The gel electrophoresis was carried out 
at 80 Volt until the samples got stacked at the lower border of the stacking gel, and 
then at 150 Volt for 1-2 Hours.
2.3.4.4 Western blotting
The protein samples separated from SDS-PAGE can be transferred onto nitrocellulose 
membranes (Hybond ECL, Amersham), on the surface of which they are accessible 
to detection with specific poly- or monoclonal antibodies. Transfer of proteins from 
the gel onto nitrocellulose membrane was done using semi-dry blotting method. The 
transfer nitrocellulose membrane and 6 sheets of Whatman filter papers of the same 
size as a gel were soaked with the transfer buffer for 15 min. The transfer stack 
was assembled from the anode to the cathode in the following order: 3 sheets of 
Whatman filter paper, transfer membrane, gel and 3 sheets of Whatman filter paper 
and during this procedure bubbles were removed. For protein transfer a constant 
current of 150 mA was applied overnight. Afterwards the blotted membrane was 
removed and stained with removable Ponceau-S stain for 2 min at RT in order to 
test the efficiency of protein transfer. It was then distained by washing for a few 
minutes in TBS-Tween.
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2.3.4.5 Immunodetection
The membrane was first incubated in blocking solution for 1 hour at RT in order to 
inhibit non-specific binding sites of antibodies to proteins. Afterwards the membrane 
was incubated with the primary antibody in appropriate dilution in the blocking solution 
overnight at 4ºC. After three washing steps for 10 min each with TBS-Tween, the 
membrane was incubated with HRP-conjugated antibody solution for 1 hour at RT, 
which binds to the heavy chain of primary antibody, followed by extensive washing 
steps. HRP coupled to the secondary antibody reduces the hydrogen peroxide and 
the resulting oxygen oxidizes the luminal, which releases the light. To visualize 
antigen-antibody reaction enzymatic chemiluminescence’s detection reagents were 
used (AceGlow reagents; psqLab biotechnoligie GmbH). The detection reagents 
were mixed according to manufacturer’s protocol. Briefly the mixture of Solution A 
and B (1:1) was poured over the membrane for 1 min at RT. The membrane was 
placed into dark chamber and a CCD camera detected the emitted light.
2.3.5 Immunocytochemistry
2.3.5.1 Brain tissue preparation
Mice were deeply anaesthetized with TBE (tribromoethanol) until they were 
unresponsive to painful stimuli. A thoracotomy was perormed and animals were 
perfused through the aorta with 0.9% sodium chloride followed by 100 ml 2 % 
paraformaldehyde in 0.1 M phosphate buffer. The whole brain was removed, post-
fixed for 1 hour in the same fixative at 4 ºC. The tissue was cryoprotected in 10-30 % 
sucrose overnight at 4 ºC. Afterwards it was frozen by tissue freezing medium on dry 
ice and stored at -80ºC. Series of transverse sections of brainstem with a thickness 
of 12 µm were cut using a cryoslicer. Each section was quickly placed on the slide. 
After sectioning the slides were kept at -80ºC.
2.3.5.2 Immunofluorescence staining
Before starting the immunostaining, the slices were washed three times with PBS. 
The blocking of non-specific binding sites and permeabilisiation of slices were done 
using 2 % NGS and 0.2-0.3 % Triton X-100 in phosphate-saline buffer (PBS) for 
20-30 min at RT. Sections were incubated overnight at 4ºC in primary antibodies 
dissolved in PBS containing 2 % NGS and 0.2-0.3 % Triton X-100. After incubation 
with primary antibodies the sections were washed 3 times for each 10 min and 
then incubated for 1 Hour at RT in the dark with species-specific flurochrome-
conjugated secondary antibodies, followed by three washing steps for 10 min each. 
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Finally, sections were slightly air-dried and coverslipped with fluorescent mounting 
medium.
2.3.5.3 Data analysis
Sections from immunofluorescence staining were visualized by confocal laser 
scanning microscopy (Zeiss LSM 510 META). The region for quantifications were 
chosen using same criteria as for electrophysiology The region of the ventrolateral 
medulla was recognized based on the appearance of nucleus ambiguus and inferior 
olive (Fig. 2.1). The region of the hypoglossal nucleus was easily identified based on 
the appearance of the nucleus (Fig. 2.1). Images (1024x1024 pixel) were recorded 
at a zoom factor of 5, using a 40x oil-immersion objective. For quantitative analyses, 
the gain and offset were held constant across all images, which give a possibility 
for intensity comparisons. For quantification, one image per mouse was chosen and 
VIAAT or VGLUT puncta were manually counted with the experimenter being blind 
respective to the genotype. Data analysis was done using commercially available 
software (Prism 4 Software, Graph Pad). 
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3. Results
3.1 MeCP2 KO mice
3.1.1 Excitatory-inhibitory imbalance appears early in the brainstem respiratory 
network of MeCP2 KO mice
Rett syndrome patients experience ventilation problems that may cause lethal 
apnea (Hanefeld et al. 1986; Kerr and Burford 2001) and the onset of these 
problems appears early in childhood (REF). Since MeCP2-deficient mice also show 
respiratory problems (Stettner et al. 2007; Viemari et al. 2005) but at an adult age 
we were interested in possible cellular defects leading to them before the onset of 




















































































Figure 3.1 Excitatory-inhibitory imbalance in the ventrolateral medulla of MeCP2 KO mice. 
(A and B) Representative ventilation traces (A) and averaged ventilation frequencies (B) of MeCP2 
mutant mice (KO) and their littermate controls (WT), measured by whole-body pletysmography at 
postnatal day P7. (C) Representative recordings of spontaneous, pharmacologically isolated (50 µM 
CNQX and 20 µM APV) inhibitory postsynaptic currents (sIPSC) from neurons in the ventrolateral 
medulla at P7. (D and E) Averaged amplitude (D) and frequency (E) of sIPSC in KO and WT neurons. 
(F) Representative recordings of spontaneous, pharmacologically isolated (1 µM strychnine and 1 
µM biccuculine) excitatory postsynaptic currents (sEPSC) from neurons in the hypoglossus nucleus 
at P7. (G and H) Averaged amplitude (D) and frequency (E) of sEPSC in KO and WT neurons. Data 
shown represent mean ± SEM. Numbers within the bar graphs indicate the number of neurons/mice 
tested for each genotype.























































































































3/3 3/3 4/4 5/5 4/4 3/3
3/3 3/3 4/4 3/34/4 5/5
Figure 3.2 Excitatory-inhibitory imbalance in the hypoglossal nucleus of MeCP2 KO mice. (A-
F) Evoked excitatory eEPSCs. Sample traces (A, B, C) and their correspondent averaged amplitude 
(D, E, F) of pharmacologically isolated eEPSCs in NH neurons from WT (black) and KO (grey) mice, 
at different stimulation intensities. (G-M) Evoked inhibitory eIPSCs. Sample traces (G, H, I) and their 
correspondent averaged amplitude (K, L, M) of pharmacologically isolated eIPSCs in NH neurons 
from WT (black) and KO (grey) mice, at different stimulation intensities. Data shown represent 
mean ± SEM. Numbers within the bar graphs indicate the number of neurons/mice tested for each 
genotype.
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ventilation activity between the hemizygous MeCP2 males (KO) compared to their 
sex- and age-matched littermate controls (WT) (Fig. 3.1A and B). However, patch-
clamp recordings of the overall activity in acute brainstem slices revealed a markedly 
depressed amplitude (WT: 73.5±0.9 pA, KO: 46±0.8 pA; p<0.001) and frequency 
(WT: 6.8±0.1 Hz, KO: 3.3±0.1 Hz; p<0.001) of spontaneous inhibitory synaptic 
currents (sIPSCs) in MeCP2-deficient mice at P7 (Fig. 3.1C-E). In contrast, both 
the amplitude (WT: 25.2±0.3 pA, KO: 34.3±0.3 pA; p<0.001) and frequency (WT: 
5.5±0.2 Hz, KO: 6.9±0.3 Hz; p<0.001) of spontaneous excitatory activity (sEPSCs) 
were slightly increased in MeCP2 KO mice compared to their littermate controls of 
the same age (Fig. 3.1F-H).
To verify if the inhibition/excitation imbalance showed above is characteristic to the 
entire network and not restricted to RVLM neurons we examined electrically evoked 
synaptic transmission in the NH. Neurons from NH receive mixed inhibitory and 
excitatory inputs from the ipsilateral RVLM neurons (Li et. al, 2003). We placed a 
bipolar stimulation electrode on the dorso-medial of the nucleus ambiguous (Missler 
et. al, 2003; Varoqueaux et. al, 2006) on the axons that leave RVLM neurons and 
make synapse with NH neurons (Li et. al, 2003). When we used lower stimulation 
intensities the evoked excitatory PSCs (eEPSC) amplitudes were unchanged 
between slices from KO mice as compared with slice from their WT littermates (at 2.5 
mA 51.2±17.8 pA in WT and 63.2±12.3 pA in KO, Fig. 3.2 A, D; at 5 mA 123.1±48.7 
pA in WT and 158.8±41.6 pA in KO, Fig. 3.2 B, E). At a stimulation intensity of 10 
mA the amplitude of evoked EPSC response was significantly higher in slices from 
KO mice (121±36.9 pA in WT and 357.3±83.2 pA in KO, p<0.05, Fig. 3.2 C, F). 
Using the same intensity stimulations we analyzed next evoked inhibitory PSCs 
(eIPSC) in the same nucleus. At stimulation intensities of 2.5 and 5 mA, there was 
no significant difference in the amplitude of evoked IPSC between genotypes (at 2.5 
mA 52.4±17.5 pA in WT and 54.4±6.4 in the KO, Fig. 3.2 G, K; at 5 mA 142±99.5 
pA in WT and 64.3±12.9 pA in KO, Fig. 3.2 H, l). As opposite to the case of evoked 
EPSCs, when we increased the stimulation intensity to 10 mA the amplitude of the 
evoked EIPSC response was significantly reduced in KO slices (316±80.9 pA in WT 
and 113±18.6 pA in KO, p<0.05, Fig. 3.2 I, M), thus confirming in NH the excitatory/
inhibitory imbalance noticed in the spontaneous PSCs in RVLM (Fig. 3.1).
These results show a specific imbalance in the network activity of respiratory 
brainstem in the MeCP2-deficient mice, thereby confirming previous data from other 
brain regions but demonstrating for the first time that these cellular impairments are 
present already at such a very early stage of central nervous system development.
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3.1.2 Miniature inhibitory synaptic transmission is depressed in the RVLM of 
MeCP2 KO mice
First, we analyzed in detail the impaired inhibitory (GABA- and glycinergic) synaptic 
transmission in the ventrolateral medulla that contains numerous inhibitory neurons 
(PBC, c.f. Richter and Spyer 2001). Since changes in spontaneous synaptic activity 
as shown above (Fig. 3.1) can be caused by pre- and/or postsynaptic defects, we 
next performed recordings of miniature postsynaptic currents (minis) in the presence 
of TTX to differentiate between the alternatives. The averaged frequency of inhibitory 
miniature postsynaptic currents (mIPSCs) was reduced by >50% from 2.25±0.1 Hz 
in WT to 1.04±0.1 Hz in MeCP2 mutant mice (p<0.001; Fig. 3.3 A, B), whereas the 
overall amplitude did not differ significantly between the genotypes (Fig. 3.3 C). 
Since the kinetics of mIPSCs was different between WT and KO recordings we 
decided to further analyze this aspect.
3.1.3 GABAergic, but not glycinergic synaptic transmission is depressed in 
the MeCP2 KO mice
In the brainstem, part of the miniature IPSCs are dual-component events comprising 
glycine- and GABA
A
-receptor-mediated currents (Nabekura et al. 2004). To distinguish 
between the two components and to test if in the MeCP2 KO mice one component 
is preferentially affected over the other, we used an exponential fitting procedure to 
separate GABAergic and glycinergic miniature events based on their different decay 
times as described before (Jonas et al. 1998; Nabekura et al. 2004) (Fig. 3.3 D; see 
Methods for a detailed description). Using this paradigm, we observed no significant 
difference in the number of mixed and glycinergic miniature events between WT and 
MeCP2 KO neurons (Fig. 3.3 E). However, the miniature events that are mediated 
by GABA alone were reduced by 50 % in mutant neurons (Fig. 3.3 E), suggesting 











Control 2.6 ± 0.4 26.8 ± 1.8 14.5 ± 1.3 700.5 ± 75.1
KO 1.8 ± 0.3 20.7 ± 1.2* 11.9± 0.8 566.2 ± 88.8


































































































Figure 3.3 GABAergic but not glycinergic miniature postsynaptic currents are decreased in 
MeCP2 KO neurons. (A) Representative recordings of pharmacologically isolated (50 µM CNQX, 20 
µM APV and 0.5 µM TTX) miniature postsynaptic currents (mIPSC) in neurons from the ventrolateral 
medulla at P7. (B and C) Averaged mean frequency (B) and cumulative amplitude (C) of mIPSCs in 
KO and WT neurons. (D) Prototypical averaged GABAergic, glycinergic and mixed mIPSC can be 
characterized by one (GABAergic with t
slow
, glycinergic with t
fast
) or two (mixed) exponential functions, 
respectively. (E) Number of GABAergic, glycinergic and mixed events in WT and KO neurons. (F) 
Representative recordings of pharmacologically isolated (50 µM CNQX, 20 µM APV, 0.5 µM TTX 
and 1 µM Strychnine) miniature GABAergic PSCs (mGPSC) in brainstem mutant and WT neurons. 
(G and H) Averaged frequency (G) and cumulative amplitude (H) of mGPSCs in mutant and WT 
neurons. (I) Representative mGPSCs currents (averaged from one trace each) from KO and WT 
mice. (J) Averaged decay time of mGPSCs in KO and WT mice, determined with a monoexponential 
fit as shown in panel (D). Data shown represent mean ± SEM. Numbers within the bar graphs 
indicate the number of neurons/mice tested for each genotype.
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that a specific reduction of GABAergic synaptic transmission is responsible for the 
reduced frequency of IPSCs in MeCP2 KO mice. To directly examine the GABAergic 
synaptic transmission, we pharmacologically isolated GABA-mediated miniature 
postsynaptic currents (mGPSCs) in the presence of 0.5 µM TTX to block action 
potential-driven release and 1 µM strychnine to suppress the glycinergic component 
(Fig. 3.3 F). Quantification demonstrated that the average frequency of mGPSC 
decreased from 1.17±0.1 Hz in WT to 0.6±0.1 Hz in MeCP2-mutant mice (p<0.001; 
Fig. 3.3 G), whereas no significant change in the amplitude of the GABAergic events 
was observed (Fig. 3.3 H). Consistent with the idea that GABA is responsible for 
the slower component of mIPSCs (Fig. 3.3D), analysis of sample traces (Fig. 3.3I) 
and quantification of the kinetics of mGPSCs (Table 3.1) revealed that the decay 
time was in fact faster in mutant neurons compared to littermate WT controls (WT: 
44.3±8.5 ms, KO: 24.4±3.1 ms; p<0.05; Fig. 3.3 J)
3.1.4 Presynaptic components of GABAergic synapses are affected in the 
MeCP2 KO mice
The reduction in frequency of miniature GABAergic synaptic events in the MeCP2 
KO mice (Fig. 3.3) may suggest that presynaptic target molecules of the MeCP2-
dependent gene regulation exist at these synapses. To independently confirm the 
presynaptic impairment of GABAergic terminals and to test if molecules involved in 
the Ca2+- independent steps of exocytosis are among the putative MeCP2 targets, 
we evoked charges of miniature GABAergic events (mGPSCs) by application of 
300 µM sucrose (Rosenmund and Stevens 1996). As evident from representative 
recordings (Fig. 3.4 A), the frequency of mGPSCs induced by the hyperosmolar 
solution was about three times higher in neurons of WT mice than of their MeCP2-
deficient littermates (Fig. 3.4 B). Since this difference reflects changes in the 
readily-releasable pool of synaptic vesicles, we performed immunofluorescence 
staining against the vesicular inhibitory transmitter transporter (VIAAT) essentially 
as described (Varoqueaux et al. 2006), using slices containing the ventrolateral 
medulla of MeCP2 KO mice and their WT littermate controls at P7 (Fig. 3.4 C-
D). Quantification revealed that the area density of VIAAT-positive punctae in the 
ventrolateral medulla was reduced in MeCP2 KO mice (8.6 ± 0.5 per 100 µm2) as 
compared with WT controls (14.9 ± 0.6 per 100 µm2; Fig. 3.4 D), with no differences 
detectable in the background intensity between genotypes. Since GABA and glycine 
can be co-released from the same vesicles (Jonas et al. 1998; Wojcik et al. 2006) 
and glycinergic release was found largely intact (Fig. 3.3), these data indicate the 
density of GABAergic synaptic vesicles and/or terminals is specifically reduced in 
the ventrolateral medulla of MeCP2-deficient mice.
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3.1.5 Impaired function and subunit composition in postsynaptic GABA 
receptors of MeCP2 KO mice
In addition to the presynaptic defect described above, our observation of reduced 
amplitudes of spontaneous inhibitory synaptic transmission in the ventrolateral 
medulla (Fig. 3.1) also raised the possibility of a postsynaptic defect, for example, in the 
expression of functional receptors. To analyze this aspect of the MeCP2 phenotype, 
we compared the responses of GABA
A 
and glycine receptors to extracellular pressure 
ejection of the corresponding receptor agonists in the presence of 0.5 µM TTX, 
















































Figure 3.4 Decreased release from GABAergic 
terminals is caused by reduced density of 
inhibitory synapses in MeCP2 KO mice. (A) 
Representative traces of miniature GABAergic 
PSCs (mGPSC) in response to application of 300 
mM sucrose (arrow) in WT and littermate KO mice. 
(B) Graph showing the time-frequency relationship 
of mGPSCs in response to the hyperosmolar 
sucrose stimulation. (C) Representative images of 
immunofluorescent stainings with anibodies against 
the vesicular GABA Transporter (VIAAT) in the 
ventrolateral medulla from WT and KO mice. (D) 
Quantification of VIAAT-positive puncta from three 
WT and KO mice (total number of punctae measured 
about 1500). Data shown represent mean ± SEM. In 
panel (B) the numbers in parentheses indicate the 
number of slices/mice tested for each genotype. 
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(Fig. 3.5 C, D), respectively. Postsynaptic responses to the GABA
A
-receptor agonist 
muscimol (5 mM) were decreased from 4.9±0.9 nA in WT to 2.2±0.9 nA in mutant 
neurons from ventrolateral medulla (p<0.05; Fig. 3.5 B), suggesting an impairment 
of functional GABA
A
 receptors. In contrast, the response to glycine (5 mM) was 
almost identical in both genotypes (WT: 2.7±0.5 nA, KO: 2.5±0.4 nA; Fig. 3.5 D). 
Interestingly, the absence of changes in glycine-mediated activity might explain the 
lack of an overt respiratory phenotype because the glycine receptor is essential for 
respiratory rhythm generation at this developmental age (Richter and Spyer 2001).
Since GABA
A
 receptors that mediate phasic synaptic inhibition predominantly contain 























































Figure 3.5 The GABA-dependent but 
not the glycine-mediated postsynaptic 
receptor response is reduced in MeCP2 
KO mice. (A and B) GABA-mediated 
postsynaptic currents. Sample traces (A) 
and averaged amplitude (B) of postsynaptic 
responses to pressure applied GABA 
agonist muscimol (5 mM) in KO and 
littermate WT neurons in the ventrolateral 
medulla at P7. (C and D) Glycine-mediated 
postsynaptic currents. Sample traces (C) 
and averaged amplitude (D) of responses 
to pressure applied glycine (5 mM) in KO 
and WT neurons. Data shown represent 
mean ± SEM. Numbers within the bar 
graphs indicate the number of neurons/



































Figure 3.6 Pharmacology of GABA
A
 receptor 
subunit α1 is not altered in the absence of 
MeCP2. (A) Representative traces of miniature 
GABAergic IPSCs (mGPSC) before and after 
zolpidem (1 µM) application in WT and KO 
neurons from the ventrolateral medulla at P7. (B) 
Averaged mGPSC currents from WT and KO mice 
before (black) and after (grey) application of 1 µM 
zolpidem. (C) Averaged decay prolongation induced 
by zolpidem in WT and KO neurons fails to detect 
differences in GABA
A 
a1- mediated responses 
between genotypes. Data shown represent mean ± 
SEM. Numbers within the bar graphs indicate the 
number of mice/neurons tested for each genotype.
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subunit present determines the deactivation kinetics of the receptor currents (Farrant 
and Nusser 2005). Faster decay times as observed here in MeCP2-mutant mice 
(Fig. 3.3 I, J) could therefore be explained, for example, by an increased expression 
of GABA
A 
receptors that contain α1 subunits (McClellan and Twyman 1999; Vicini 
et al. 1998). To test this possibility, we utilized a specific GABA
A
-receptor agonist, 
zolpidem, which shows a high affinity for GABA
A 
α1 subunit. In the presence of 
functional GABA
A
 receptors containing α1 subunit, zolpidem prolongs the decay 
time of miniature events (Perrais and Ropert 1999). Consistent with these studies, 
addition of 1 µM zolpidem induced a 30% increase in the decay time of mGPSC in 
both WT and MeCP2-deficient mice (Fig. 3.6 A-D). While zolpidem did not cause 
a change in frequency or amplitude (data not shown), the results indicate that an 
increased expression of postsynaptic GABA
A 
α1 subunit is unlikely to be responsible 
for the shortening of the decay time in MeCP2-mutant mice. 
Since pharmacological means to distinguish between different GABA
A 
receptor 
subunit compositions are very limited, we directly compared the protein levels of 
different GABA
A
 receptor subunits and glycine receptors in mutant and WT mice. 
Quantitative immunoblots of brainstem lysates showed that relative level of the 
GABA
A
 α2 subunit was decreased by more than 30% (p<0.01), while the levels of 
GABA
A
 α1, α3, α4 and β3 subunits, and of glycine receptors were not significantly 
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Figure 3.7 Protein levels of the GABA
A
 a2 receptor subunit are specifically decreased in MeCP2 
KO mice. (A) Representative immunoblots of GABA
A
 receptor subunits a1, a2, a3, a4 and b3, glycine 
receptor GlyR, and heat shock protein Hsp70 as input control. (B) Quantitative analysis of the protein 
levels of GABA
A
 and glycine receptor subunits in brainstem lysates of littermate control (open bars, 
WT) and MeCP2 deficient mice (closed bars, KO) at postnatal day 7. Data shown represent mean ± 
SEM. Numbers within the bar graphs indicate the number of repeats for the respective experiment. 
Four pairs of littermate WT and KO mice were used for each experiment.
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3.1.6 Miniature excitatory synaptic transmission is depressed in the 
hypoglossal nucleus of MeCP2 KO mice
Since we noticed that the network excitatory activity is increased in the respiratory 
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Figure 3.8 Miniature glutamatergic synaptic transmission is reduced in the NH of MeCP2 KO 
mice. (A) Representative recordings of pharmacologically isolated miniature glutamatergic PSCs 
from neurons in NH. (B, C) Averaged amplitude (E) and cumulative distribution of frequency (F) of 
miniature glutamatergic PSCs in KO and control neurons. (D, E) Sample traces of averaged miniature 
glutamatergic events (D) and weighted mean decay time from KO and control neurons. Data shown 
represent mean ± SEM. Numbers within the bar graphs indicate the number of neurons/mice tested 
for each genotype.
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investigation of excitatory synapses. In order to analyze if functional synaptic changes 
are the basis of network related impairments of excitatory (glutamatergic) synaptic 
transmission described above, we performed miniature excitatory postsynaptic 
recordings (mEPSCs) in neurons from the hypoglossus nucleus in the presence of 
0.5 µM tetradotoxin. We chose to record neurons from the NH nucleus because the 
presence of all type of excitatory synapses and glutamatergic receptor subunits on 
these neurons has been extensively described (Paarman et al., 2000 and 2005). 
To our surprise, both the amplitude (32.8±0.5 pA in WT and 29.1±0.4 pA in KO, 
p<0.001, Fig. 3.8 A, B) and the frequency (3.8±0.2 Hz in WT and 2.6±0.1 Hz in KO, 
p<0.001, Fig. 3.8 A, C) of mini EPSCs was significantly reduced in neurons from KO 
mice as compared to neurons from their WT littermates. Moreover kinetic analysis 
showed that the KO excitatory minis decay significantly slower (Fig. 3.8 D, E) as 
compared to the ones recorded from WT neurons (6.1±2.3 ms in WT and 34.5±11.4 
ms in KO, p<0.05). Other kinetic parameters showed no significant change between 
genotypes (Table 3.2).
3.1.7 Presynaptic defects of excitatory synapses in the NH nucleus of MeCP2 
KO mice
The significant reduction in the frequency of mEPSCs in the NH of MeCP2KO 
mice prompt us to verify if impairments in the synaptic density may be the cause of 
this phenotype. We performed immunofluorescence staining against the vesicular 
glutamate transporters 1 and 2 (VGLUT 1 & VGLUT2). We used slices containing 
the hypoglossal nucleus of MeCP2 KO mice and their WT littermate controls at 
P7 (Fig. 3.9 A). Quantification revealed that the area density of VGLUT-positive 
punctae in the ventrolateral medulla was reduced in MeCP2 KO mice (8.6 ± 0.5 
per 100 µm2) as compared with WT controls (14.9 ± 0.6 per 100 µm2; Fig. 3.9 B), 











WT 0.8 ± 0.2 6.2 ± 2.3 3.2 ± 1.0 191.1 ± 41.6
KO 1.2 ± 0.2 34.5 ± 11.4* 4.6± 0.7 296.0 ± 60.2
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with no differences detectable in the background intensity between genotypes. 
These are preliminary results, but they confirm a previous study that showed that 
the presynaptic excitatory phenotype on synaptic transmission in autaptic cultures is 
explained by a reduced number of glutamatergic synapses (Chao et. al., 2007).
3.1.8 Reduction of specific subunits of NMDA and AMPA receptors in the 
medulla of MeCP2 KO mice
Ionotropic lutamatergic postsynaptic receptors are separated into 3 major groups: 
NMDA, AMPA and kainate (Hollmann and Heinemann, 1994). The difference in the 
amplitude and the decay times of mEPSCs between wild-type and MeCP2 KO mice 
may be explained by changes in the subunit composition of different glutamatergic 
postsynaptic receptors. Thus, we performed semiquantitative immunoblot analysis 
on brainstem homogenates from WT and KO mice, investigating the expression of 
some important subunits of NMDA and AMPA receptors at this stage of development 
(Fig. 3.10 A, B) since kainite receptors are weakly expressed in brainstem at this 
age (Paarman et. al, 2000). NMDAR2A subunit showed a ∼ 60% reduction in its 















Figure 3.9 Reduced density of excitatory synapses in the NH of MeCP2 KO mice. (A) 
Representative images of immunofluorescent stainings with anibodies against the vesicular glutamate 
transporters 1 & 2 (VGLUT 1 &2) in the NH from WT and KO mice. (B) Quantification of VGLUT-
positive puncta from one WT and one KO mouse. (total number of punctae measured about 400). 
Data shown represent mean ± SEM.
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their wild-type littermates. On the other hand, GluR1 subunit of AMPA receptors 
showed a mild but significantly increased expression in the medulla of the MeCP2 
KO mice (Fig. 3.10 A, B; p<0.01).  None of the other subunit investigated showed 
significant different expression levels between WT and KO homogenates. The 
NMDAR2A subunit is the one that confers faster kinetics to NMDA receptors (Cull-
Candy et. al., 2001) and the AMPA receptors have faster decays as well (Hollmann 
and Heinemann, 1994). Thus, these data are in line with the kinetics data shown 
above (Fig. 3.8 D, E)
In order to test functionally if the reduction of one subunit of NMDA receptors has an 
effect on the total membrane expression of the receptor we compared the responses 
of NMDA
 
and AMPA receptors to extracellular pressure ejection of the corresponding 
receptor agonists. Experiments were performed on RVLM neurons, in the presence 
of 0.5 µM TTX, 1µM strychnine/bicuculine and 40 µM AP5 (Fig. 3.11 A, B) or 10 
µM CNQX (Fig. 3.11 C, D), respectively. Postsynaptic responses to AMPA (5 mM) 
were similar in WT and mutant neurons from ventrolateral medulla (1172±179.3 pA 
in WT to 993.1±176 pA; Fig. 3.11 A, B). The response to NMDA (5 mM), although it 
appeared increased in KO RVLM neurons as compared to WT neurons (225.2±42.4 
pA in WT and 352.9±49.7 pA in KO, Fig. 3.11 C, D) was not statistically significant. 
3.1.9 Summary of the MeCP2 KO results
Our data show that, in the absence of MeCP2, spontaneous and evoked inhibitory 
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p<0.05 p<0.01
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Figure 3.10 Protein levels of glutamate receptor specific subunits are changed in MeCP2 
KO mice. (A) Representative immunoblots of NMDA and AMPA receptor subunits with heat shock 
protein Hsp70 as input control. (B) Quantitative analysis of the protein levels of NMDA and AMPA 
receptor subunits in medulla lysates of littermate control (open bars, WT) and MeCP2 deficient mice 
(closed bars, KO) at postnatal day 7. Data shown represent mean ± SEM. Numbers within the bar 
graphs indicate the number of repeats for the respective experiment. Four pairs of littermate WT and 
KO mice were used for each experiment.
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2). The reduction is due to a specific reduction in the strength of GABAergic, 
synapses (Fig. 3.3-6). On the other hand both spontaneous and evoked excitatory 
synaptic transmission is enhanced in the same network (Fig.3.1-2) probably due to 
changes in network plasticity, since the miniature excitatory synaptic transmission 
is decreased (Fig.3.8). In MeCP2 KO mice we noticed a decrease in the density 
of presynaptic markers for inhibitory (VIAAT) (Fig.3.4) and excitatory (VGLUT) 
synapses (Fig.3.9). At the postsynaptic site, specific alterations of expression levels 
of GABA and glutamate receptor subunits (Fig. 3.7; Fig. 3.10) are present. From 
these data, we conclude that MeCP2 is involved in formation and maturation of both 














































Figure 3.11 The postsynaptic NMDA and AMPA receptor response to direct agonists is 
unchanged in the RVLM of MeCP2 KO mice. (A and B) AMPA-mediated postsynaptic currents. 
Sample traces (A) and averaged amplitude (B) of postsynaptic responses to pressure applied AMPA 
(5 mM) in KO and littermate WT neurons in the ventrolateral medulla at P7. (C and D) NMDA-mediated 
postsynaptic currents. Sample traces (C) and averaged amplitude (D) of responses to pressure 
applied NMDA (5 mM) in KO and WT neurons. Data shown represent mean ± SEM. Numbers within 
the bar graphs indicate the number of neurons/mice tested for each genotype.
                Results
49
3.2 NL1 KO mice
3.2.1 NL1 KO mice show normal physiology and normal neuronal excitability 
NL 1-3 TKO mice die within hours after birth due to a respiratory failure and published 
experiments from our group revealed that both glutamatergic and GABA/glycinergic 
synaptic transmission in the respiratory brainstem are severely reduced (Varoqueaux 
et. al., 2006). In order to compare the effect that the deletion of NL-1 alone has on 
ventilation characteristics and/or synaptic function we performed our experiments 
on postnatal day 1 (P1) using the same experimental paradigms. NL1 KO mice are 
born normal and there is no difference neither in the appearance nor the body weight 
between them and their WT and HZ littermates (1.7±0.05 g in control vs. 1.9±0.1 g 
in KO mice; Fig. 3.12. C). Because the NL TKOs show a severe respiratory failure at 
this age, we measured the respiratory ventilation by whole-body pletysmography in 
the NL1 KO mice and their control littermates. No difference could be seen between 
genotypes (2.5±0.1 Hz in control vs. 2.6±01. Hz in KO mice; Fig 3.12. A, B). Next, we 
recorded voltage-activated Na+, K+ and Ca2+ currents in the NH and RVLM neurons 
in order to see if the deletion of NL1 impairs neuronal excitability. In all cases the 
density of measured currents was the same between the NL1 KO mice and their 
control littermates (Na+: 101.9±5.9 pA/pF in control vs. 79.4±9.7 pA/pF in KO mice; 
K+: 135.7±7.7 pA/pF in control vs. 157.8±10.9 pA/pF in KO mice; Ca2+: 17.8±1.2 in 






































Figure 3.12 Normal physiology of early postnatal NL-1 KO mice. (A, B) Representative ventilation 
traces (A) and averaged ventilation frequencies (B) of neuroligin mutant mice (KO) and their littermate 
controls (WT & HZ) as measured by whole-body plethysmography at postnatal day P2. (C) Averaged 
body weight of neuroligin mutant mice (KO) and their littermate controls (WT & HZ). Data shown 
represent mean ± SEM. Numbers within the bar graphs indicate the number of mice tested for each 
genotype.












































































Figure 3.13 Neuronal excitability is normal in NL-1 KO mice. Representative traces of voltage-
activated Na+ (A), K+ (C) and Ca2+ (E) currents and the corresponding mean current densities (B, D, 
F) from KO and control neurons. Data shown represent mean ± SEM. Numbers within the bar graphs 
indicate the number of neurons/mice tested for each genotype.
3.2.2 Spontaneous, but not miniature GABAergic and glycinergic synaptic 
transmission is reduced in NL1 KO mice 
Next, we analysed GABAergic and glycinergic synaptic transmission in RVLM 
neurons since this component of synaptic transmission was the one most affected 
in the NL TKO mice (Varoqueaux et. al., 2006). Both amplitude and frequency of 
pharmacologically isolated spontaneous GABAergic and glycinergic PSCs were 
significantly reduced in the NL1 KO mice as compared with their control littermates 
(67.5±1.5 pA and 3.8±0.1 Hz in control vs. 58.9±1.5 pA and 2.3±0.1 Hz in KO mice; 
p<0.001 in both cases; Fig. 3.14 A, B, C). In addition we analysed miniature GABAergic 
and glycinergic neurons in the same RVLM neurons in the presence of 0.5 µM TTX, 
a blocker of action-potential dependent synaptic transmission. The amplitude and 
frequency of miniature GABAergic and glycinergic PSCs was unchanged between 
the genotypes (36.3±1.1 pA and 1.1±0.05 Hz in control mice vs. 39.2±1.5 pA and 











































































































































































Figure 3.14 GABA- & glycinergic spontaneous network activity, but not miniature synaptic 
activity, is reduced in NL-1 KO mice. (A) Representative recordings of pharmacologically 
isolated spontaneous GABA- & glycinergic PSCs from neurons in NH. (B, C) Averaged amplitude 
(B) and frequency (C) of spontaneous GABA- & glycinergic PSCs in KO and control neurons. (D) 
Representative recordings of pharmacologically isolated miniature GABA- & glycinergic PSCs from 
neurons in RVLM. (E, F) Averaged amplitude (E) and frequency (F) of miniature GABA- & glycinergic 
PSCs in KO and control neurons. (G, H) Sample traces of averaged miniature GABA- & glycinergic 
events (D) and their weighted mean decay time from KO and control neurons. Data shown represent 
mean ± SEM. Numbers within the bar graphs indicate the number of neurons/mice tested for each 
genotype.
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Figure 3.15 Spontaneous, miniature and evoked glutamatergic synaptic transmission 
is reduced in NL-1 KO mice. (A.) Representative recordings of pharmacologically isolated 
spontaneous glutamatergic PSCs from neurons in NH. (B, C) Averaged amplitude (B) and frequency 
(C) of spontaneous glutamatergic PSCs in KO and control neurons. (D, E) Sample traces (D) and 
averaged amplitude (E) of evoked glutamatergic PSCs in NH neurons from KO and control mice. 
(F) Representative recordings of pharmacologically isolated miniature glutamatergic PSCs from 
neurons in NH. (G, H) Averaged amplitude (G) and frequency (H) of miniature glutamatergic PSCs 
in KO and control neurons. (I, J) Sample traces of averaged miniature glutamatergic events (I) and 
their weighted mean decay time from KO and control neurons. Data shown represent mean ± SEM. 
















































































































































































s) p < 0.05
Control
1.1±0.1 Hz in KO mice; Fig. 3.14. D, E, F). Furthermore, analysis of mini kinetics did 
not reveal any difference, nor in decay time (36.9±8.4 ms in control vs. 38.3±7.1 ms 
in KO mice; Fig. 3.14 G, H) neither in other parameters (Table 3.3), suggesting that 
inhibitory synaptic function is not affected in the NL-1 KO mice.
3.2.3 Spontaneous, miniature and evoked glutamatergic synaptic transmission 
is decreased in NL1 KO mice
Since NL1 is mostly expressed at glutamatergic synapses (Song et al, 1999), we 
recorded the glutamatergic synaptic transmission in neurons from the hypoglossal 
nucleus. We pharmacologically isolated glutamatergic PSCs and we noticed that 
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both their amplitude and frequency was significantly reduced in NL1 KO mice as 
compared with their control littermates (33.4±0.4 pA and 3.6±0.1 Hz in control vs. 
27.7±0.4 pA and 2.7±0.1 Hz in KO mice; p<0.001 in both cases; Fig. 3.15 A-C). 
Next we analysed miniature glutamatergic synaptic transmission in NH neurons in 
the presence of 0.5 µM TTX. While the amplitude of miniature glutamatergic PSCs 
showed no significant difference between genotypes (28.4±0.4 pA in control vs. 
29.1±0.9 pA in KO mice; Fig.3.15 F, G) their frequency was reduced in NL1 KO 
mice to ∼50% of the control values (1.8±0.1 pA in control vs. 0.9±0.1 Hz in KO mice; 
p<0.001; Fig. 3.15 F, H). Beside the presynaptic phenotype (the ∼50 decrease in 
frequency) analysis of the decay time of mEPSC revealed a ∼50% reduction in the 
KO mice (26.3±4.5 ms in control vs. 13.0±2.6 ms in KO mice; p<0.05; Fig. 3.15 I, J; 
Table 3.3). Thus, we chose to electrically evoke glutamatergic PSCs in NH neurons in 
order to have a different approach to investigate possible postsynaptic changes. For 
this purpose we stimulated axons from the RVLM neurons and we recorded neurons 










Control 1.6 ± 0.5 36.9 ± 8.4 15.1 ± 2.7 630.3 ± 98.7
KO 1.8 ± 0.3 38.3 ± 7.1 16.4 ± 1.8 883.6 ± 96.2
mEPSC
Control 1.6 ± 0.2 26.3 ± 4.5 5.8 ± 0.6 300.2 ± 24.6
KO 1.2 ± 0.2 13.0 ± 2.6* 4.4 ± 0.6 241.7 ± 37.9
mNMDA
Control 3.2 ± 0.5 32.9 ± 3.7 15.3 ± 1.5 524.0 ± 51.6
KO 2.2 ± 0.5 22.2 ± 3.1* 10.0 ± 1.3* 478.1 ± 78.4
mAMPA
Control 1.1 ± 0.1 12.1 ± 2.4 5.5 ± 0.6 373.6 ± 52.7
KO 0.9 ± 0.1 10.9 ± 3.8 5.2 ± 1.5 377.1 ± 61.7
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in the NH in the presence of 1µM bicuculline and 1µM strychnine. Compared to the 
evoked glutamatergic PSCs amplitude in neurons from control mice, the amplitude 
in neurons from NL1 KO mice was strongly decreased (238.5±39.0 pA in control vs. 
63.7±20.9 pA in KO mice; Fig. 3.15 D, E).
3.2.4 NMDA, but not AMPA synaptic transmission is affected in NL1 KO mice
Since different postsynaptic receptors have different kinetics we decide to further 
investigate glutamatergic synaptic transmission in the NL-1 KO mice. For this purpose 






























































































Figure 3.16 NMDAergic miniature postsynaptic currents are impaired in postnatal NL-1 KO 
mice. (A) Representative recordings of pharmacologically isolated miniature NMDAergic PSCs 
from neurons in NH. (B, C) Averaged amplitude (E) and cumulative distribution of frequency (F) of 
miniature NMDAergic PSCs in KO and control neurons. (D, E) Sample traces of averaged miniature 
NMDAergic events (D) and weighted mean decay time from KO and control neurons. Data shown 
represent mean ± SEM. Numbers within the bar graphs indicate the number of neurons/mice tested 
for each genotype.
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NH neurons in the presence of 1µM Strychnine, 1µM bicuculline, 0.5 µM TTX and 10 
µM CNQX or 40 µM AP5. The frequency of miniature NMDA PSCs was reduced in 
slices from NL KO1 mice to ∼50% as compared to slices from their control littermates 
(1.0±0.1 Hz in control vs. 0.5±0.1 Hz in KO mice; p<0.001; Fig. 3.16 A, C), while 
the frequency of miniature AMPA PSCs was unchanged regardless of the genotype 
(1.2±0.1 Hz in control vs. 1.1±0.1 Hz in KO mice; Fig. 3.17 A, C). The amplitude 
of miniature NMDA PSCs was higher in the NL1 KO mice (26.7±0.5 pA in control 
vs. 30.2±1.1; p<0.05; Fig. 3.16 A, B). On the other side, the amplitude of miniature 





























































































Figure 3.17 AMPAergic miniature postsynaptic currents are normal in postnatal NL-1 KO 
mice. (A) Representative recordings of pharmacologically isolated miniature AMPAergic PSCs 
from neurons in NH. (B, C) Averaged amplitude (E) and cumulative distribution of frequency (F) of 
miniature AMPAergic PSCs in KO and control neurons. (D, E) Sample traces of averaged miniature 
AMPAergic events (D) and weighted mean decay time from KO and control neurons. Data shown 
represent mean ± SEM. Numbers within the bar graphs indicate the number of neurons/mice tested 
for each genotype.
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with control (34.5±1.0 pA in control vs. 32.4±1.4 pA in KO mice; Fig.17 A, B) and it 
is most probable that it masked the mEPSC amplitude (Fig. 3.15 F, G). Finally, we 
analysed the decay times of both miniature NMDA and AMPA PSCs. The decay 
time of miniature NMDA PSCs was significantly lower in slices from NL1 KO mice 
(32.9±3.7 ms in control vs. 22.2±3.1 ms in KO mice; p<0.05; Fig. 3.16 D, E; Table 
3.3), and it probably underlies the kinetic changes noticed in mEPSC (Fig. 3.15 I, 
J) since the decay of miniature AMPA PSCs was unchanged between genotypes 
(12.1±2.4 ms in control vs. 10.9±3.8 ms in KO mice; Fig.3.17 D, E; Table 3.3).
3.2.5 Summary of the NL-1 KO results
The NL-1 KO mice present a reduction in both inhibitory and excitatory spontaneous 
synaptic transmission, but only changes in the miniature and evoked activity of 
excitatory synapses were found (Fig. 3.14-15). Moreover, we show that only the 
function of NMDAergic and not AMPAergic synapses is altered in the absence of 
NL-1 (Fig. 3.16-17). Altough further experiments need to be done, changes in the 
frequency, amplitude and decay time of NMDA minis (Fig. 3.16) suggest structural 
changes in the NMDA synapses. From these data, we conclude that NL-1 plays an 
important role in the maturation of NMDA synapses. 
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3.3 Nbea KO mice
3.3.1 Neurobeachin null-mutant mice die at birth
Nbea (-/-) were smaller in size and they were easily identified from their wild-type 
and heterozygous littermates by their prominent hunch (Fig. 3.18). Nbea (-/-) pups 
were cyanotic, displayed no spontaneous movement and died immediately at birth 
due to primary asphyxia. The reason for such lethal primary asphyxia in Nbea (-/-) 
mice might be either failure in the peripheral organogenesis or neuronal impairments 
in the peripheral and/or central nervous system. In our experiments, the gross 
anatomy of the most vital organs, such as heart, lung, however, did not show any 
obvious abnormality (data not shown) that might explain the lethal phenotype. On 
the other hand, previous data demonstrated that deletion of Nbea-gene caused a 
complete block of neuromuscular synaptic transmission (Su et al., 2004). As Nbea 
is not present in muscle (Su et al., 2004), the primary cause of the lethal asphyxia 
in Nbea (-/-) mice might be of neuronal nature. We therefore performed a series of 
experiments on mice of embryonic stage E18-19 obtained by Caesarean section (cf. 
Methods). In E18-19, Nbea (-/-) mice showed no spontaneous movement and did not 
react to mechanical stimuli as compare to their heterozygote and WT littermates.
3.3.2 The function of voltage-activated channels is not altered in Nbea-KO 
mice
Since Nbea KO mice die at birth we chose to investigate a brain region that is fully 
functional at perinatal stage, the respiratory brainstem (Richter and Spyer, 2001). We 
analyzed different cellular functions in acute slices in two brainstem areas: the pre-
Bötzinger complex (preBötC) and the hypoglossal nucleus. This double approach 
A
Figure 3.18 Nbea deletion in mice is leading to immediate postcaesarian death. Smaller body 
size and typical hunch-pack appearance of Nbea-knockout mice (right) at E18 delivered by cesarean 
section.
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ensures that the apparent phenotypes are independent of a particular area or type 
of synapse. Another advantage of this network is that is well established as a model 
for studying synaptic maturation in lethal mutant mouse models (Missler et al., 2003; 
Varoqueaux et. al, 2006).
As mentioned before, Nbea has been proposed to be involved in the post-Golgi 
sorting or targeting of neuronal membrane proteins, such as proteins of ion-channels, 
receptors and other membrane proteins. Thus, the lethal phenotype of Nbea-KO 
mice might be caused by impairment of ion channels in neuronal membranes. To 
directly test the function of ion channels in Nbea-KO mice, we recorded whole-cell 
currents of Na+-, K+- and Ca2+-channels in the pre-Bötzinger area of the brainstem 
that is essential for generating normal respiratory rhythm (Richter and Spyer, 2001). 
As shown in Fig. 3.19, whole-cell recordings of voltage-activated Na+-currents were 
similar between control and KO mice (Fig. 3.19 A, B control: 91.3±12.5 pA/pF; KO: 
79.3±8.6 pA/pF; n.s.). Furthermore, no significant changes could be found in current 










































































Figure 3.19 Voltage-activated currents are unchanged in Nbea KO mice. Representative traces 
of voltage-activated Na+ (A), K+ (C) and Ca2+ (E) currents and the corresponding mean current 
densities (B, D, F) from wild-type and neurobeachin knockout neurons. Data shown represent mean 
± SEM. The numbers within the bars represent the number of neurons/mice tested.
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Figure 3.20 Decreased spontaneous and miniature release at glutamatergic synapses in Nbea 
KO mice. (A) Representative recordings of pharmacologically isolated spontaneous glutamatergic 
sEPSCs in brainstem RVLM neurons. (B, C) Averaged amplitude (B) and frequency (C) of spontaneous 
glutamatergic sEPSCs in mutant and WT neurons. (D) Representative recordings of miniature 
glutamatergic mEPSCs in brainstem RVLM neurons. (E, F) Averaged amplitude (E) and frequency 
(F) of miniature glutamatergic mEPSCs in mutant and WT neurons. (G) Frequency distribution of 
glutamatergic mEPSCs in RVLM neurons of littermate control (grey) and neurobeachin KO mice 
(black). Data shown represent mean ± SEM. The numbers within the bars represent the number of 
neurons/mice tested.
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KO: 151.3±18.6 pA/pF; n.s.) or Ca2+-channels (Fig. 3.19 E, F; control: 14.6±2.8 
pA/pF; KO: 15.6±1.7 pA/pF; n.s.). Thus, although KO-mice did not survive due to 
respiratory failure, the neurons were intact and no obvious functional failures could 
be found in voltage-dependent ion channels within the respiratory network. 
3.3.3 Excitatory synaptic transmission is diminished in Nbea-KO mice
Neurobeachin expression is highly enriched in the central nervous system (Wang 
et al.) and we reasoned that central synapses could be affected in the absence 
of Nbea. To direct challenge the question whether deletion of Nbea-gene might 
compromise the targeting of synaptic proteins and thus also the synaptic function, 
we next monitored the spontaneous excitatory postsynaptic currents (sEPSCs) using 
whole-cell recording in neurons of hypoglossal nucleus in the presence of 1 µM 
bicuculine and 1 µM strychnine. The frequency of sEPSCs in hypoglossal neurons 
was decreased in Nbea-KO mice (Fig. 3.20 A, C; control: 2.5±0.3 Hz; KO: 1.6±0.2 
Hz; p<0.01), while the amplitude was not affected (Fig. 3.20 A, B; control: 22.8±0.6 
pA; KO: 23.8±0.5 pA; n.s.). We further analyzed miniature excitatory postsynaptic 
currents (mEPSC) in the presence of 0.5 µM TTX. The frequency of mEPSC was 
clearly reduced in Nbea-KO mice (Fig. 3.20 D, F, G; control: 1.1±0.1; KO: 0.2±0.05; 
p<0.001), but the amplitude of mEPSCs was not significantly changed between the 
genotypes (Fig. 3.20 D, E; control: 24.7±0.6 pA: KO: 23.7±1.3 pA; n.s.). In addition, 
analysis of the kinetics of mEPSCs revealed also no significant difference between 
the KO and the control group (see Table 3.4).
3.3.4 Inhibitory synaptic transmission is severely compromised in Nbea-KO 
mice
It is known that inhibition is essential for respiratory rhythm generation (Richter and 
Spyer, 2001) and the majority of synapses within the respiratory network is in fact 
inhibitory (McKay et al., 2005). We therefore monitored spontaneous glycine- and 
GABAergic inhibitory postsynaptic currents (sIPSCs) in preBötC neurons in the 
presence of 10 µM CNQX and 40 µM APV. Here both the amplitude (Fig. 3.21 A, B; 
control: 93.7 ± 5.8 pA; KO: 33.7 ± 6.7 pA; p < 0.001) and the frequency (Fig. 3.21 A, 
C; control: 2.1 ± 0.2 Hz; KO: 0.35 ± 0.1 Hz; p<0.001) of sIPSCs in preBötC neurons 
were dramatically diminished in neurobeachin KO mice. This dramatic decrease 
in the spontaneous inhibitory network activity together with changes in excitatory 
transmission (Fig. 3.19) is probably the reason for the lethal respiratory failure in the 
Nbea KO mice (Richter and Spyer, 2001).
The above conspicuous changes in the sIPSCs could be caused by either pre- or/
and postsynaptic defects.  To answer this question we further analyzed the miniature, 
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Figure 3.21 Deletion of neurobeachin almost abolishes inhibitory synaptic transmission. 
(A) Representative recordings of pharmacologically isolated spontaneous glycine- and GABAergic 
sIPSCs in brainstem RVLM neurons. (B, C) Averaged amplitude (B) and frequency (C) of spontaneous 
glycine- and GABAergic sIPSCs in mutant and WT neurons. (D) Representative recordings of 
miniature glycine- and GABAergic sIPSCs in brainstem RVLM neurons. (E, F) Averaged amplitude 
(E) and frequency (F) of miniature glycine- and GABAergic sIPSCs in mutant and WT neurons. (G) 
Frequency distribution of glycine- and GABAergic mIPSCs in RVLM neurons of control (grey) and 
neurobeachin KO mice (black). Data shown represent mean ± SEM. The numbers within the bars 
represent the number of neurons/mice tested.
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action-potential independent, glycine- and GABAergic inhibitory postsynaptic 
currents (mIPSCs) in the presence of 0.5 µM TTX. The frequency of mIPSCs in 
Nbea KO mice was so dramatically decreased (Fig. 3.21 D, F; control: 0.7 ± 0.2 
Hz; KO: 0.05 ± 0.04 Hz; p < 0.001) that the miniature events were almost totally 
abolished in KO mice (Fig. 3.21 G). Despite the depletion of mIPSCs, the amplitudes 
of the remaining miniature events were only moderately decreased in KO mice (Fig. 
3.21 D, E; control: 44.4 ± 4.2 pA; KO: 25.3 ± 4.9 pA; p<0.01), whereas no significant 
changes were noticed in the kinetic parameters of the mIPSC between the KO and 
control mice (see Table 3.4). These data, thus, suggest rather a presynaptic defects 
in KO mice. 
To exclude the possibility of a postsynaptic defect, we compared the responses of 
glycine receptors to extracellular pressure ejection of 5 mM glycine in the presence 
of 0.5 µM TTX, 10 µM CNQX, 40 µM AP5, and 1µM bicuculine. The amplitude of 
the response to glycine was similar between genotypes (Fig. 3.22 A, B; control: 
2.22 ± 0.8 nA; KO: 1.55 ± 0.3 nA; n.s.), suggesting no significant changes in the 
postsynaptic site in the absence of neurobeachin.
The next question was whether the impairment of sIPSCs and mIPSCs in neurobeachin 
KO mice reflects a fundamental dysfunction of synapses that particularly applies to 
action potential evoked transmitter release. We examined evoked IPSCs of neurons 
of hypoglossal nucleus in presence of 10 µM CNQX and 40 µM APV by extracellular 
field stimulation of preBötC neurons. Compared to control mice, the averaged 
amplitude of eIPSCs did not change significantly in Nbea KO mice (Fig. 3.22 C, D; 
control: 118.7 ± 54.8 pA; KO: 93.7 ± 55.3 pA; n.s.). On the other hand, the failure 










Control 2.0 ± 0.6 46.2 ± 13.0 11.5 ± 0.9 715.6 ± 166.8
KO 2.2 ± 0.5 29.9 ± 13.5 10.0± 1.8 652.2 ± 266.3
mEPSC
Control 1.7 ± 0.4 32.5 ± 18.0 5.9 ± 1.0 293.9 ± 49.8
KO 1.6 ± 0.5 23.8 ± 9.5 3.4 ± 0.4 171.7 ± 26.7
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rate of stimulation evoked IPSCs manifested from 3 ± 1.9 % in control mice to 66.4 
± 11.8 % in KO mice (p < 0.001; Fig. 3.22 E). Taken together, these data point to 
presynaptic defects in both inhibitory and excitatory synaptic transmission. 
3.3.5 Modified abundance of multiple synaptic proteins in Nbea KO mice
In order to find the cellular clues of the reported functional impairments in the Nbea-
KO mice, we analysed the expression levels in whole-brainstem lysates of several 
pre- and postsynaptic protein markers by using quantitative Western blotting. Among 
the 15 presynaptic proteins tested, the relative levels of the synaptophysin and 
synapsin I&II, which are among the most abundant components of synaptic vesicles 
(Takamori et al, 2006) were reduced to ~50% in Nbea KO mice. In addition, SV2 
and Mint-1 were also significantly decreased, while the levels of other proteins were 
unchanged in mutant mice (Fig. 3.23 A, B). There were also no significant changes 
in the levels of the vesicular transporters VIAAT and VGAT between the KO and the 
control group. At the postsynaptic site, the levels of tested NMDAR1 subunits were 
significantly decreased, while the levels of other postsynaptic proteins tested were 














































































Figure 3.22 Increased failure rate with intact postsynaptic receptors characterize inhibitory 
synapses of Nbea KO mice. Sample traces (A) and averaged amplitudes (B) of brainstem RVLM 
neurons in mutant and WT mice in response to pressure-ejected glycine. Sample traces (C), failure 
rates (D), and averaged amplitudes (E) of evoked glycine- and GABAergic IPSC in mutant and WT 
neurons in response to extracellular stimulation. Data shown represent mean ± SEM. The numbers 
within the bars represent the number of neurons/mice tested.


































































































































Figure 3.23 Expression levels of several synaptic marker proteins are decreased in Nbea KO 
mice. (A) Representative immunoblots of pre- and postsynaptic proteins in WT and Nbea KO mice, 
using actin and heat shock protein (Hsp70) as input control. (B) Quantitative analysis of the protein 
levels from brainstem lysates of littermate wild-type (open bars, WT) and Nbea-deficient mice (closed 
bars, KO) at embrionyc day E18. Data shown represent mean ± SEM. Three pairs of littermate WT 
and KO mice were used for each experiment.
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3.3.5 Summary of the Nbea KO results
Deletion of Nbea causes a significant reduction of both excitatory and inhibitory evoked 
and spontaneous synaptic transmission in the respiratory brainstem (Fig. 3.20-22), 
leading to immediate postnatal death. Analysis of miniature currents showed that the 
function of both inhibitory and excitatory synapses is severely reduced (Fig. 3.20-
21) The perturbed excitatory and inhibitory synaptic transmission in Nbea KOs is 
due to altered pre- and postsynaptic functions (Fig. 3.20, 3.21, 3.22) that most likely 
caused by aberrant cell surface and synaptic recruitment of presynaptic proteins 
and postsynaptic receptors (Fig. 3.23). Moreover, work done by our collaborators 
show that deletion of Nbea also leads to a reduction of both the number of synapses 
and the number of transmitter vesicles in presynaptic terminals  (Fig.4.2). Thus, we 
show that Nbea is an essential protein for the formation of inhibitory and excitatory 
central synapses.
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4.Discussions
4.1 Synaptic imbalance appears early in the developing neural 
networks of mice models of ASD
4.1.1 Inhibition is the functional driving force of the respiratory network
We performed the experiments in the present study on unidentified neurons within the 
ventrolateral medulla that contains both respiratory and none-respiratory neurons. 
Nevertheless, since it was shown that the majority of the neurons from this structure 
are involved in respiration (Smith et. al., 1991) it is quite likely that the results of the 
present study do apply for respiratory rhythm-generating network. 
Both RTT patients and MeCP2 KO mice suffer from respiratory irregularities (Chahrour 
et. al., 2007). Our analysis of MeCP2 KO mice demonstrate that inhibitory and 
excitatory spontaneous and evoked network activity in the RVLM and NH is already 
altered in early postnatal mutant mice (Fig. 3.1), however no obvious impairment in 
the overall ventilation activity was evident at this age (Viemari et al. 2005). As for the 
NL-1 KO mice, although both inhibitory and excitatory synaptic transmission was 
reduced, no changes in ventilation activity were noticed (Fig. 3.12-14), in contrast 
with the ventilation irregularities found in the NL-2 KO mice (Aramuni et.al., in 
review) or with the respiratory failure that accompanies the deletion of NL-1, 2 and 
3 (Varoqueaux et al., 2006). In the case of Nbea-KO mice the severe impairment of 
excitatory and especially inhibitory synaptic transmission in brainstem respiratory 
network (Fig. 3.20-21) is probably leading to apnea. We conclude that, the central 
respiratory failure together with the general peripheral paralysis causes the early 
lethal phenotype of the Nbea (-/-) mice.
The absence of overt respiratory problems in the case of MeCP2 and NL-1 KO 
mice may be surprising with respect to such a strong cellular phenotype, however, 
the respiratory network is known to be one of the most robust networks due to the 
redundant assembly of its connectivity that confers stability against disturbances 
(Feldman and Del Negro 2006; Richter and Spyer 2001). As we notice in the case 
of the Nbea KO mice or in the previous studies of neuroligin-2 KO mice (Aramuni 
et.al., in review), neurexin triple KO mice (Missler et al., 2003) and neuroligin 
triple KO mice (Varoqueaux et al., 2006), a reduction of inhibitory network activity 
of 50% or more was necessary to cause first visible irregularities in the resting 
ventilation activity (Aramuni et.al., in review), and only a reduction of more than 
80% caused a life-threatening failure of ventilation (Missler et al., 2003; Varoqueaux 
et al., 2006) (Fig. 4.1). As inhibition is an essential process for the neurons from 
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RVLM in generating the respiratory rhythm (Richter and Spyer, 2001), this is most 
probable the underlying cause of failure in the respiratory rhythm generation and 
our comparison between different studied models support this notion (Fig. 4.1). 
Therefore, a moderate reduction of less than 50% of inhibitory network activity 
as reported in the present study of MeCP2–deficient mice and NL-1 KO mice is 
not expected to change resting ventilation activity but may have an effect on the 
adaptability of the respiratory network during stressful activities. 
4.1.2 Disinhibition and hyperexcitability in the brainstem respiratory network 
of MeCP2 KO mice
Published data on impairments of synaptic transmission in MeCP2-deficient mice are 
controversial with respect to the components affected: in the hippocampus, loss of 
MeCP2 caused enhanced excitatory transmission (Moretti et al. 2006), and reduced 
paired-pulse facilitation and LTP (Asaka et al. 2006; Moretti et al. 2006), whereas 
Dani et al. (2005) showed that MeCP2 KO mice present a reduction of excitatory 
activity and an increase of spontaneous but not miniature IPSC in neocortical layer 5 




























Figure 4.1 Inhibition in the brainstem respiratory network is essential for ventilation. The 
frequency of excitatory PSCs (red arrows) is less important than the frequency of inhibitory PSCs 
(blue arrows) in determining the outcome of ventilation function (√ means normal ventilation; ∼√ 
means normal ventilation, but irregular and X means failure of ventilation)
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of miniature EPSCs is decreased (Nelson et al. 2006), with no effect on either the 
frequency and amplitude of mIPSCs (Nelson et al. 2006). Although the divergent 
results may reflect the different brain regions and ages investigated, these studies 
uniformly emphazised the general importance of the balance between inhibitory and 
excitatory synaptic transmission for the ethiology of RTT, and is confirmed by our 
current findings in the brainstem (Fig. 3.1-2). Our data in the respiratory medulla 
show that both evoked and spontaneous inhibitory synaptic transmission is reduced 
in the MeCP2 KO mice. Extending the previously published data, we now show that 
it is specifically the GABA- but not the glycine-mediated component of inhibitory 
synaptic transmission that is significantly compromised in MeCP2 mutants (Fig. 3.3-
5).
On the other hand, the data about excitatory synaptic transmission in the present study 
are contradictory (Fig. 3-1-2; Fig 3.8). We have found that, although the strength of 
excitatory synapses is reduced (reduced mEPSC frequency and amplitude; Fig 3.8) 
in the hypoglossal nucleus, the network spontaneous and evoked excitatory activity 
in hypoglossal nucleus and RVLM is enhanced (Fig. 3-1-2; Fig 3.8). However, in 
the same MeCP2 KO line that we use, Zhang et. al.(2007) shows similar results in 
the adult hippocampus. Using whole-cell patch clamp and extracellular recordings, 
Zhang et. al. (2007) shows that the frequency of the IPSP-driven spontaneous 
rhythmic field potentials (SFRP) (extracellular) is reduced, along with the correlated 
IPSP (intracellular). Spontaneous glutamatergic activity in CA1 is reduced in the KO 
mice (Zhang et. al. 2007), however at high-frequency-stimulation (HFS), the system 
is prone to hyperexcitability. Chronic hyperexcitability, induced by a reduction in 
the frequency of spontaneous inhibitory PSCs in the functional maturation of the 
brainstem may be a possible explanation for our data. For example, induced chronic 
periods of hyperexcitability in different systems (Turrigiano et. al., 1998; O’Brien et 
al., 1998; Swann et. al., 2007) resulted in a dramatic decrease in the frequency and 
amplitude of mEPSC, as in our results. These changes may be due to intervention 
of activity-dependent homeostatic mechanisms (Turrigiano and Nelson, 2004), 
with the excitatory synapses trying to scale down their activity in order to maintain 
the proper excitatory/inhibitory balance. One other possible explanation for the 
difference between increase in the network excitatory PSCs and the decrease in 
the excitatory minis lies in the function of MeCP2 as a regulator of DNA methylation. 
Recently, it was shown that inhibitors of DNA methylation decrease the frequency 
of miniature excitatory PSC and this effect is mediated by MeCP2 (Nelson et. al., 
2008). Moreover, the authors find that the effect of the DNA methylation inhibitors on 
mEPSCs overlaps with the effects induced by chronic hyperexcitability, suggesting 
a shared mechanism between the two in the control of spontaneous miniature 
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synaptic transmission (Nelson et. al., 2008).
4.1.3 Specific reduction of the function of NMDA synapses underlies the 
network impairments in the NL-1 KO mice
Deletion of Neuroligin 1, 2 and 3 leads to reductions in the activity of both inhibitory 
and excitatory synapses (Varoqueaux et. al., 2006), thus the study of individual 
knockouts can bring more information about the specific function of each isoform at 
each type of synapse. Consistent with the available results from the neuroligin field, 
our analysis of the NL-1 KO mice showed that the deletion of the protein affects mainly 
excitatory neurotransmission and has no effect on the inhibitory miniature synaptic 
transmission (Fig. 3.14-15). The decrease in the spontaneous inhibitory synaptic 
transmission is probably the result of reduced excitatory input in the network.  In 
comparison, the study of NL-2 KO mice revealed that the inhibitory, but not excitatory 
synaptic transmission is reduced in the absence of NL-2 (Aramuni et. al., in review). 
Previous study in in vitro systems showed that overexpression of NL-1 specifically 
cluster postsynaptic components of excitatory synapses, leading to an increase 
in the frequency and amplitude of miniature excitatory currents (Chih et. al, 2005; 
Prange et. al., 2004). More specific, overexpression of NL-1 in hippocampal neurons 
primary cultures enhances both NMDA- and AMPA-evoked responses (Chubykin et. 
al., 2007). However, in the same study it was shown that deletion of NL-1 in mice 
induces a ∼50% reduction in the NMDA evoked response in hippocampal slice, with 
no change in the AMPA-mediated evoked response (Chubykin et. al., 2007). Our 
present study confirms that only the function of NMDAergic synapses is affected in 
the absence of NL-1 (Fig. 3.16). However, we notice a decrease in the frequency of 
miniature NMDA currents and, in opposition with Chubykin et. al. (2007) the amplitude 
of NMDA minis is increased. One possible explanation for this discrepancy lies in 
the faster decay time noticed by us in the NMDA minis from KO mice (Fig. 3.16, D, 
E). Faster decay times of NMDA currents are characteristic to the NMDA receptors 
that include NR2A subunits in their composition and NR2A subunits confers a higher 
amplitude to the NMDA receptor in which they are incorporated (Cull-Candy et. 
al., 2001; Vicini et. al., 1998; Monyer et. al., 1994), Thus, if this is the case, that 
may explain the discrepancies between our data and the results of Chubykin et. al. 
(2007). Moreover, NR2A subunits affect more the miniature currents than the evoked 
ones, as shown by the deletion of NR2A in mice (Townsend et.al., 2003). This may 
explain the difference in amplitude between our results and Chubykin et. al. (2007), 
as  well as the difference between our increased miniature NMDA amplitude and the 
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significantly decreased amplitude of the evoked excitatory PSCs (Fig. 3.15). 
 4.1.4 Loss of Nbea disrupts the function of inhibitory synapses leading to 
network failure
First experimental evidence about the function of Nbea has been shown in a null mutant 
mouse line obtained by coincidental insertion mutagenesis. There, homozygous 
Nbea (-/-) mice were found to die immediately after birth, and displayed a complete 
block of evoked transmission at the neuromuscular junction (NMJ) whereas nerve 
conduction, NMJ morphology and spontaneous quantal release were normal (Su 
et al., 2004). The present study reveals that Nbea-KO mice suffer from apnea 
attributable to a severe impairment of excitatory and especially inhibitory synaptic 
transmission in brainstem respiratory network. The activity of both excitatory and 
especially inhibitory synapses is almost abolished.  Regarding the functional role 
of Nbea, both the previous study (Su et al., 2004) and the current results point to 
a strong involvement of Nbea in synaptic function. Nevertheless, there are several 
discrepancies between the functional role of Nbea in the peripheral and central 
nervous system that might be very crucial for understanding the mechanisms of 
Nbea function. In the neuromuscular junction axons of motoneurons are able to 
form synapses that exhibit normal spontaneous AP-independent neurotransmitter 
release (mepps) but is unable to sustain evoked AP-dependent responses at the 
same synapse in Nbea-null mice (Su et al., 2004). In the present study, both AP-
dependent (evoked and spontaneous) and AP-independent (miniature) synaptic 
transmissions are severely impaired in brainstem respiratory network (Fig. 3.20-22). 
One possible explanation of these discrepancies may lie in the differences in the 
functional assembly between CNS and NMJ synapses, as shown by other studies of 
proteins essential for synaptic transmission. In the Munc-13-1/2-DKO mice evoked 
and spontaneous synaptic transmission in hippocampus is entirely abolished 
(Varoqueaux et al., 2002) while at NMJ both are reduced but still present (Varoqueaux 
et al., 2005). SNAP-25 mutant mice present increased spontaneous transmission at 
the NMJ (Washbourne et al., 2002) and almost abolished spontaneous transmission 
in cortical slices (Tafoya et al., 2006), with the evoked neurotransmission being 
abolished at both synapses. One the other hand, the rich expression of Nbea in 
the CNS as compared with the muscle (Su et al., 2004), along with morphological 
and biochemical synaptic changes (see 4.2.3) suggest that the protein plays an 
essential role in the formation of central synapses, while at the NMJ other proteins 
may compensate its function.
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4.2 Specific impairments in synaptic maturation underlie the 
network imbalance in mice models of ASD
4.2.1Both pre- and postsynaptic components of inhibitory and excitatory 
synapses are affected in the absence of MeCP2
4.2.1.1 Excitatory and inhibitory synaptic density is reduced in the absence of 
MeCP2
The reduced frequency of GABAergic synaptic transmission in MeCP2 KO mice 
is due to a reduction of specific presynaptic (Fig. 3.4) components. Our findings 
of reduced punctae of VIAAT in the RVLM of MeCP2 mutant mice suggest a role 
for MeCP2 in the regulation of genes important for the formation, function and 
maintenance of inhibitory synapses. This is the first time when a reduction in the 
number of inhibitory synaptic markers is shown in the MeCP2 KO mice. Our current 
results are consistent with the demonstration that BDNF is a target of MeCP2 
transcriptional repression (Chang et al. 2006) because BDNF promotes GABAergic 
synaptogenesis (Carrasco et al. 2007; Marty et al. 2000; Yamada et al. 2002), and 
the BDNF receptors appear to be abundant in the ventrolateral medulla of neonatal 
mice (Thoby-Brisson et al. 2003). Moreover, we measured the expression of the 
excitatory synaptic markers VGLUT (1 and 2) in the hypoglossal nucleus and we 
found a reduction in the number of VGLUT punctae in the MeCP2 KO mice (Fig. 3.9). 
This may explain the reduction in the excitatory mini frequency described above (Fig. 
3.8). These data are inline with recently published data that MeCP2 might play a key 
role in regulating glutamatergic synapse formation in early postnatal development 
(Chao et al. 2007).
4.2.1.2 Postsynaptic developmental maturation is impaired in the MeCP2 KO mice 
The maturation of GABA synapses depends upon switches of distinct subunits of 
many receptor and channel classes, e.g., in the thalamus and cortex of rats the 
GABA
A
 receptor subunits undergo a change from α2 (or α3) to α1 during postnatal 
development (Bosman et al. 2002; Fritschy et al. 1994). Here, we found that in 




 receptors in 
the ventrolateral medulla was significantly decreased, as shown independently by 
immunoblotting and quantitative RT-PCR experiments (Medrihan et. al, 2008). As 
GABA
A
 receptors generally consist of two α, two β and one γ subunits (Baumann 
et al. 2001; Farrant and Nusser 2005), the α2
 
subunit is very abundant in early 
postnatal ages in many brain regions (Laurie et al. 1992; Liu and Wong-Riley 
2004) and is subsequently downregulated in the adult. However, in regions like 
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hippocampus, neocortex or midbrain, postnatal α2 expression does not decrease 
and is maintained at the same level in adult life (Laurie et al. 1992; Liu and Wong-
Riley 2004). Interestingly, changes in GABA
A
 receptor subunit composition can 
be correlated with an alteration of binding kinetics and allosteric properties of the 
GABA
A
 receptor (Okada et al. 2000). The decrease in the expression of GABA
A
 α2 
subunit observed in our study (Fig. 3.7) could explain the changes in the decay time 
of mGPSCs (Fig. 3.3), whereas the alternative explanation of a changed expression 
of GABA
A
 α1 subunit was not validated (Fig. 3.6-7). Our results on altered GABA
A
 
receptor composition in MeCP2 knockout mice are consistent with decreased 
benzodiazepine receptor binding in brains of RTT patients (Yamashita et al. 1998). 
However, another recent study reported a downregulation in the GABA
A 
β3 subunit 
expression levels in both RTT patients and two strains of MeCP2 deficient mice 
(Samaco et al. 2005) which was not altered in our study. Our observation of a 
changed expression of the α2 subunit of the GABA
A
 receptor in MeCP2 KO mice 
may be relevant to symptoms in RTT patients: the α2 containing GABA receptors are 
expressed in synapses located mainly on axon initial segment (Brunig et al. 2002; 
Cruz et al. 2003) of the reticular activating system, limbic system, amygdala and 
hippocampus (Rudolph and Mohler 2004), where it mediates the anxiolytic action of 
benzodiazepines (Low et al. 2000). These data suggest that α2 containing GABA 
receptors are crucially involved in processing of emotional stimuli (Rudolph and 
Mohler 2004), and its downregulation as reported here could provide an explanation 
of the autism-like symptoms of Rett syndrome patients.
The maturation of the glutamatergic synapses is a long-term process involving 
changes in both the ultrastructure and the electrophysiologichal properties 
(McAllister, 2007). One of the main characteristics at the postsynaptic site is the 
developmental switch to receptor subunits that speed the synaptic transmission in 
mature synapses (Cull-Candy et. al., 2001; Takahashi, 2005). At NMDA receptors, 
a developmental switch between the slow decay NR2B subunit and the fast decay 
NR2A subunit takes place (Cull-Candy et. al., 2001; Takahashi, 2005; Monyer et. 
al., 1994; Vicini et. al., 1998). In the MeCP2 KO mice we noticed a decrease in the 
expression levels of the NR2A subunit (Fig. 3.10), underlying the slower kinetics 
noticed in the excitatory minis (Fig. 3.8). These results suggest the importance of 
MeCP2 in the developmental maturation of the synapses: like GABA
A
α2, NR2A is 
also a subunit whose incorporation in synapses is developmentally regulated (Cull-
Candy et. al., 2001; Takahashi, 2005). The importance of this process is increased 
by the fact that mutations in GRIN2A, the gene that encodes the NR2A subunit 
showed high significant association with ASDs, (Persico and Bourgeron, 2006). Our 
results show also an increase in the GluR1 subunit of postsynaptic AMPA receptors 
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(Fig 3.10). An increased expression of GluR1 should result in faster decay times and 
higher amplitudes (Takahashi, 2005), which is not the case in our experiments (Fig. 
3.8) Since GluR1 receptors are weakly expressed in the hypoglossal nucleus but 
strongly expressed in the inferior olive (Paarman et. al., 2000) it may be that these 
discrepancies are due to different regional expression of the subunit. 
4.2.2 Deletion of NL-1 leads to impairments in the maturation of NMDAergic 
synapses
The ∼50% reduction in the frequency of NMDA minis  (Fig. 3.15-16) may be the 
result of a similar reduction in the density of NMDA synapses. Previous studies have 
correlated changes in expression of NL-1 in culture systems with changes in the 
density of excitatory synapses (Dean et. al., 2003; Chih et. al., 2005; Levinson et al., 
2005). Our study is still at a preliminary stage, so we do not know if a reduction in the 
number of NMDAergic synapses is the cause of the changes in frequency noticed. 
However, since in the NL TKO the density of excitatory synapses is not affected 
(Varoqueaux et. al., 2006) we do not presume that this is the case.
NMDA receptors play critical roles in the plasticity and excitotoxicity of the CNS. As 
described above (see 4.2.1.2), they are tetramers composed of two NR1 subunits 
and two different NR2 (from A to D) subunits (Cull-Candy et. al., 2001). The identity 
of the NR2 subunit influences, among other properties, the time course of the 
excitatory PSCs(Cull-Candy et. al., 2001; Vicini et. al., 1998).   Our observation of 
a faster decay time of NMDA miniature currents lead us to speculate of a change 
in the subunit composition of NMDA receptors in the NL-1 mutant mice. Compared 
with results from Paarman et. al. (2000) and O’Brien et. al., (1997) we find that the 
decay time of our NMDA minis in the WT mice from NH is comparable  to those 
obtained by them in the same nucleus at a aproximatively similar age (second 
postnatal week) ( 32 ms for our study (Table 3.3); 38 ms for Paarman et. al. (2000) 
and 42 ms for O’Brien et. al. (1997)). In another study, Paarman et. al. (2005) shows 
that in the NH  the NR2A, NR2B and NR2D subunits are highly expressed. Based 
on these data we can explain the faster decay time by either an enrichment in the 
expression of NR2A subunits since the decay times of NR2A are the fastest: NR2A 
< NR2B<<NR2C (Cull-Candy et. al., 2001). Since the interaction of NL-1 with PSD-
95 has been extensively characterized (Irie et al., 1997; Prange et. al., 2004) and 
PSD-95 is responsible for bringing the NR2A subunits at the synapse (Sans et. 
al., 2000) we may speculate that NL-1 plays a role in the postsynaptic maturation 
of NMDA synapses. In line with this hypothesis, experiments from NLTKO mice or 
NL-2 KO mice showed that the expression of specific subunits of GABA receptors 
is reduced in the KOs (Varoqueaux et. al., 2006; Aramuni et. al., in review). Thus, 
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different members of the Neuroligin family may control the glutamatergic/GABAergic 
postsynaptic differentiation and by this the excitatory/inhibitory network balance.
4.2.3 Nbea is essential for the formation of central synapses
Despite the complete absence of evoked synaptic transmission in NMJ, the number, 
the structure and the maturation of neuromuscular synapses appear normal in 
Nbea-null mice (Su et al., 2004). Our analysis of the distribution and ultrastructure 
of brainstem synapses reveals a reduction of both synaptic density and the number 
of synaptic vesicles per presynaptic terminals in brainstem RVLM of Nbea-KO mice 
(Fig. 4.2). The reduced number of synapses could at least partly explain the reduced 
frequency of miniature EPSC and IPSC (Fig. 3.20-21) in the brainstem synapses of 
Nbea-KO mice. Thus, our data provide evidence that Nbea is required for formation 
and functional assembly of central synapses, but is not essential for NMJ.
Taken together, the electrophysiological and morphological data presented sofar 
point to a strong presynaptic phenotype. Indeed, our analysis of the presynaptic 
markers revealed that several key protein of the presynaptic machinery, such as 
synaptophysin, SV2, Mint-1, are downregulated in the Nbea KO mice (Fig. 3.23). 
Synaptophysin1 KO has been shown to be not essential for neurotransmitter release 
(McMahon et al., 1996), while SV2A/SV2B are essential for Ca2+-dependent 
release (Janz et al., 1999). On the other hand, synapsin-TKO causes decrease of 
inhibitory synaptic transmission decreased (Gitler et al., 2004), whereas Mint1-KO 
Figure 4.2 Ultrastructure of synapses is affected in the neurobeachin-deficient mice. (A – D) 
Electron micrographs of representative synapses (asterisks) in the ventral rostral medulla of littermate 
control (A, B) and knockout animals (C, D). Presynaptic terminals of mutant mice contain synaptic 
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impairs GABAergic inhibitory synaptic transmission (Ho et al., 2003). But, despite 
their involvement in presynaptic exocytosis the complete lost the above presynaptic 
proteins does only moderately impair synaptic functions and almost all the null-
mutant mice are viable, except for the SV2A/SV2B DKO (McMahon et al., 1996; Janz 
et al., 1999; Gitler et al., 2004; Ho et al., 2003). Therefore, a moderate reduction of 
presynaptic proteins as shown in the present study (Fig. 3.23) cannot be the primary 
cause of the lethal phenotype of Nbea-null mice. These data, thus, suggest that 
Nbea the reduced of presynaptic proteins, might be the consequence of reduced 
number of synapses or the reduced number of vesicles noticed in the brainstem of 
Nbea KO mice (Fig. 4.2), but not the primary cause for the phenotype. 
In the present study the amplitude of spontaneous IPSCs is significantly reduced in 
Nbea-KO mice. Nbea-KO also reveals a tendency of reduced decay time in mIPSC 
and mEPSC (Table 3.4). In addition the amount of postsynaptic NMDA-Receptor 
was significantly reduced in brainstem homogenates of Nbea-KO mice. Thus, these 
data point to an additional postsynaptic phenotype, even not in the same extent as 
the presynaptic phenotype of Nbea-KO mice. These findings also differ from the 
previous finding that the function of postsynaptic AchR is normal in NMJ of Nbea-
null mice and the absence of evoked epps could not be explained by disruption of 
postsynaptic function (Su et al., 2004). One possible explanation of this discrepancy 
is that the postsynapses of NMJ are not neuronal where Nbea does not play a 
functional role in the postsynaptic assembly in NMJ. 
4.3 General discussions
Unlike brain diseases caused by sudden lesions, the clinical symptoms of 
developmental disorders result from complex interactions among many brain 
regions, networks, and proteins. We show here that the maintenance of a proper 
balance between excitation and inhibition in a neural network is a delicate process 
that starts early in development. Furthermore, we show that changes in both the 
maturation and the function of inhibitory and/or excitatory synapses underlie the 
network imbalance and further the output function of the network. 
The resting ventilation is normal in the MeCP2 and NL-1 mice and is absent in the 
Nbea KO mice. Since respiratory network is a highly modulated and compensated 
network (Feldman and Del Negro 2006; Richter and Spyer 2001) we show that more 
than ∼50% reductions in network inhibitory activity are necessary to produce visible 
changes in the ventilation (Fig. 4.1).
An early imbalance in the network activity underlied by changes in synaptic function 
is noticed in all our mice models. In all the mice analysed we see a reduction in 
inhibition, produced either by direct reduction in the function of inhibitory synapses, 
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as it it the case for Nbea KO mice, or even more specific, by direct reduction in the 
function of GABAergic synapses, as it results from the deletion of MeCP2. As for the 
NL-1 KO mice, the reduction in inhibition is probably an indirect effect induced by 
the reduction in excitation, since at this age both GABA and glycine are excitatory 
due to the depolarizing Cl- reversal potential (Ben-Ari et al., 2004). The reduced 
excitation in the NL-1 KO mice is underlied by a specific reduction in the function 
of NMDAergic synapses and in the case of Nbea, by a general reduction of the 
function of excitatory synapses. In the absence of MeCP2 it was surprising to notice 
that the network is prone to hyperexcitability, although the function of excitatory 
synapses is reduced. Our interpretation of this data is that the network is trying to 
balance the loss-of-function at synaptic level by homeostatic mechanism (Nelson 
et. al., 2008). It may be possible in the case of MeCP2 KO mice that this imbalance 
may eventually lead to the apparition of the later severe phenotype of these mice, 
at an age when the modulatory systems can not counterbalance anymore this loss-
of-function.
In the mice models we analysed we notice structural changes at the synaptic level 
that may represent the underlying cause of the described functional imbalance. 
In the absence of MeCP2 the density of both excitatory and inhibitory synapses 
is reduced, strengthening the synaptogenic role that was proposed for this 
transcriptional repressor (Zoghbi, 2003). A reduction in the density of synapses is a 
dramatic effect especially starting at such an early stage of the development, when 
the network is barely formed, and it may lead to severe impairments in its future 
development. In the absence of Nbea not only the density, but also the presynaptic 
organization of inhibitory and excitatory synapses is severely altered, suggesting an 
important role for this protein in the formation of synapses. Indeed, the function of 
the Nbea KO synapses is almost abolished, leading to respiratory failure, paralysis 
and immediate death. Due to such effects Nbea KO mice are not suitable mice 
models for ASDs since it is obvious that in autistic patients such a loss-of-function is 
not present. It may be the case that point mutations in the gene, as the one noticed 
in patients (Castermans et. al., 2003), may lead to a milder effect, with the protein 
partially maintaining its function.
One interesting aspect noticed in the analysed mice is the loss of specific postsynaptic 
receptor subunits, such as GABA
A
α2 or NMDAR2A. These subunits are normally 
under strict developmental regulation, and their incorporation in the respective 
receptors at specific developmental times gives specific kinetic properties (Takahashi, 
2005; Cull-Candy et. al., 2001; Farrant and Nusser, 2005) and their absence may 
lead to temporal network imbalance, disabling the capacity of the network to react 
to activity-dependent changes. The downregulation of these subunits in the MeCP2 
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KO mice and probably in the NL-1 KO mice suggest that these proteins play also an 
important role in maintaining the temporal network imbalance.
In conclusion, each of the protein analysed plays an important role in the function 
and maturation of the synapses and their absence leads to spatio-temporal network 
imbalance. Their adjacent association with autistic spectrum disorders suggest that 
these neurodevelopmental disorders may have an earlier cellular onset than it is 
believed. It may be possible that these early network imbalance, barely noticeable 
in the unstressful life of an infant may manifest itself when the environmental factors 
and/or the multitude of sensorial stimuli subject the network to adaptive stress. Since 
early diagnostics are essential in the treatment of ASDs we can only hope that our 
present work may bring a little more knowledge to the few we have about the onset 
of these terrible disorders.
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5. Summary
Maintaining a proper balance between excitation and inhibition is a key feature of 
neural networks. Autistic spectrum disorders (ADSs) have been proposed to result 
from an excitatory/inhibitory network imbalance caused by synaptic impairments. 
Mice models in which selected candidate genes are mutated were generated and 
the behavioural phenotype of these mice presented strong similarities with the 
symptoms of human patients. However, the developmental onset of these symptoms 
is still largely unknown.
Here, we analysed three mice models in which genes that cause special forms of 
ASDs (MeCP2), belong to a family responsible for many cases of ASDs (NLGN-1) 
or their mutations induce cases of idiopathic ASD (NBEA) have been knocked-out. 
Since all of these proteins are presumably involved in formation and maturation, we 
investigated the functional and structural synaptic and subsequent network changes 
caused by their absence in the first postnatal week. We used the brainstem respiratory 
network as an experimental model, since this network is functional immediately after 
birth.
Our results show that the deletion of these proteins in mice leads to specific 
alterations in the function and the maturation of the synapses starting from an earl 
developmental stage. The deletion of MeCP2 results in a decreased density of both 
inhibitory and excitatory synapses and in the reduced expression of developmentally 
important GABA and NMDA postsynaptic receptor subunits. The absence of NL-1 
leads to reduced function of NMDAergic synapses, while the Nbea KO mice present 
severe alterations in the formation and function of both excitatory and inhibitory 
synapses. These synaptic impairments are translated in imbalance in the overall 
network inhibition and excitation, and the severity of this imbalance is correlated 
with the ability of the neural network to perform its output function, in our case 
respiration. 
From our data we hypothesise that early developmental synaptic changes in the 
genetic mice models of ASDs may lead to the loss of experience-dependent synaptic 
plasticity noticed in these mice models and to their behavioural symptoms. 
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